AUUDW Auddia Inc

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒	Quarterly REPORT pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2024
Or
☐	Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from _____________ to _____________

 

Commission File No. 001-40071

 

AUDDIA INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware		45-4257218
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
1680 38th Street, Suite 130 Boulder, CO		80301
Address of Principal Executive Offices		Zip Code

 

(303) 219-9771

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		AUUD		The Nasdaq Stock Market
Warrants, each exercisable for one share of Common Stock		AUUDW		The Nasdaq Stock Market

 

Indicate by check mark whether the registrant: (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer ☐	Accelerated Filer ☐
Non-accelerated Filer ☒	Smaller Reporting Company ☒
	Emerging Growth Company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12(b)-2 of the Exchange Act). Yes ☐  No ☒

 

As of November 7, 2024, there were 5,673,675 shares of the registrant’s common stock, $0.001 par value per share, outstanding.

 

 

 

AUDDIA INC.

2024 QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

 

		Page No.
PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements	4
	Condensed Balance Sheets	4
	Condensed Statements of Operations	5
	Condensed Statements of Changes in Shareholders’ Equity	6
	Condensed Statements of Cash Flows	7
	Notes to Condensed Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	33
Item 4.	Controls and Procedures	33
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	34
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34
Item 3.	Defaults Upon Senior Securities	34
Item 4.	Mine Safety Disclosures	34
Item 5.	Other Information	34
Item 6.	Exhibits	35
	Signatures	37

 

 

 

 

 

 

 

 

 

 

Unless we state otherwise or the context otherwise requires, the terms “Auddia,” “we,” “us,” “our” and the “Company” refer to Auddia Inc., a Delaware corporation.

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q, or Quarterly Report, contains forward-looking statements that involve risks and uncertainties. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements other than statements of historical facts contained in this Quarterly Report are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “expects”, “intends”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, “continue” or the negative of these terms or other comparable terminology.

 

Forward-looking statements are neither historical facts nor assurances of future performance, and are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

 

	·	the sufficiency of our existing cash to meet our working capital and capital expenditure needs over the next 12 months and our need to raise additional capital;
	·	our ability to generate revenue from new software services;
	·	our limited operating history;
	·	our ability to maintain proper and effective internal financial controls;
	·	our ability to continue to operate as a going concern;
	·	changes in laws, government regulations and policies and interpretations thereof;
	·	our ability to obtain and maintain protection for our intellectual property;
	·	the risk of errors, failures or bugs in our platform or products;
	·	our ability to attract and retain qualified employees and key personnel;
	·	our ability to manage our rapid growth and organizational change effectively;
	·	the possibility of security vulnerabilities, cyberattacks and network disruptions, including breaches of data security and privacy leaks, data loss, and business interruptions;
	·	our compliance with data privacy laws and regulations;
	·	our ability to develop and maintain our brand cost-effectively; and
	·	the other factors set forth elsewhere in this Quarterly Report and in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2023.

 

These forward-looking statements speak only as of the date of this Form 10-Q and are subject to business and economic risks. We do not undertake any obligation to update or revise the forward-looking statements to reflect events that occur or circumstances that exist after the date on which such statements were made, except to the extent required by law.

 

 

 

 

PART I – FINANCIAL INFORMATION

 

Item 1.

Financial Statements

 

Auddia Inc.

Condensed Balance Sheets

 

		September 30, 2024				December 31, 2023
			(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents		$	3,773,827			$	804,556
Accounts receivable, net			292				494
Prepaid assets			63,823				50,608
Other current assets			10,039				7,150
Total current assets			3,847,981				862,808
Non-current assets:
Property and equipment, net of accumulated depreciation			14,228				18,099
Intangible assets, net of accumulated amortization			3,482				3,947
Software development costs, net of accumulated amortization			2,678,716				3,347,935
Operating lease right of use asset			81,386				–
Deferred offering costs			65,905				170,259
Total non-current assets			2,843,717				3,540,240
Total assets		$	6,691,698			$	4,403,048
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued liabilities		$	441,726			$	911,664
Notes payable to related party, net of debt issuance costs			–				3,025,000
Current portion of operating lease liability			23,374				–
Stock awards liability			26,276				45,964
Total current liabilities			491,376				3,982,628
Non-current operating lease liability			63,654				–
Total liabilities			555,030				3,982,628
Commitments and contingencies (Note 5)							–
Shareholders' equity:
Series B Preferred stock - $0.001 par value, 2,314 and 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively			2				–
Common stock - $0.001 par value, 100,000,000 authorized and 5,673,675 and 854,162 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively			5,674				854
Additional paid-in capital			93,237,155				80,962,896
Accumulated deficit			(87,106,163	)			(80,543,330	)
Total shareholders' equity			6,136,668				420,420
Total liabilities and shareholders' equity		$	6,691,698			$	4,403,048

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 

 

 

Auddia Inc.

Condensed Statements of Operations

(Unaudited)

 

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2024				2023				2024				2023
Revenue		$	–			$	–			$	–			$	–
Operating expenses:
Direct cost of services			54,916				43,470				153,316				130,809
Sales and marketing			282,450				316,297				645,713				765,176
Research and development			233,085				227,133				558,180				617,622
General and administrative			881,439				777,496				2,826,563				2,596,831
Depreciation and amortization			495,960				465,166				1,473,088				1,350,820
Total operating expenses			1,947,850				1,829,562				5,656,860				5,461,258
Loss from operations			(1,947,850	)			(1,829,562	)			(5,656,860	)			(5,461,258	)
Other expense:
Interest expense			(1,578	)			(286,920	)			(170,933	)			(1,133,398	)
Change in fair value of warrants			–				–				(632,388	)			–
Total other expense			(1,578	)			(286,920	)			(803,321	)			(1,133,398	)
Loss before income taxes			(1,949,428	)			(2,116,482	)			(6,460,181	)			(6,594,656	)
Provision for income taxes			–				–				–				–
Net loss		$	(1,949,428	)		$	(2,116,482	)		$	(6,460,181	)		$	(6,594,656	)
Net loss per share attributable to common stockholders
Basic and diluted		$	(0.50	)		$	(2.65	)		$	(2.51	)		$	(10.28	)
Weighted average common shares outstanding
Basic and diluted			3,920,409				797,889				2,570,299				641,723

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 

 

 

Auddia Inc.

Condensed Statements of Changes in Stockholders’ Equity

for the Three and Nine Months Ended September 30, 2024 and 2023

(Unaudited)

 

		Series B Preferred Stock								Common Stock
		Number of Shares				Par Value				Number of Shares				Par Value				Additional Paid-In-Capital				Accumulated Deficit				Total
Balance, December 31, 2023			–			$	–				854,162			$	854			$	80,962,896			$	(80,543,330	)		$	420,420
Issuance of common shares, net of costs			–				–				1,340,034				1,340				3,605,168				–				3,606,508
Offering costs			–				–				–				–				(44,404	)			–				(44,404	)
Share-based compensation			–				–				–				–				173,289				–				173,289
Net loss			–				–				–				–				–				(2,207,328	)			(2,207,328	)
Balance, March 31, 2024			–				–				2,194,196				2,194				84,696,949				(82,750,658	)			1,948,485
Issuance of common shares, net of costs			–				–				600,000				600				1,245,400				–				1,246,000
Issuance of Series B preferred stock and warrants			2,314				2				–				–				2,238,573				–				2,238,575
Conversion of debt to equity			–				–				–				–				1,543,772				–				1,543,772
Offering costs			–				–				–				–				(97,333	)			–				(97,333	)
Share-based compensation			–				–				–				–				132,488				–				132,488
Net loss			–				–				–				–				–				(2,303,425	)			(2,303,425	)
Balance, June 30, 2024			2,314				2				2,794,196				2,794				89,759,849				(85,054,083	)			4,708,562
Issuance of common shares, net of costs			–				–				2,875,263				2,876				3,320,665				–				3,323,541
Issuance of restricted stock units			–				–				4,216				4				(4	)			–				–
Capitalized dividends			–				–				–				–				102,652				(102,652	)			–
Offering costs			–				–				–				–				(65,423	)			–				(65,423	)
Share-based compensation			–				–				–				–				119,416				–				119,416
Net loss			–				–				–				–				–				(1,949,428	)			(1,949,428	)
Balance, September 30, 2024			2,314			$	2				5,673,675			$	5,674			$	93,237,155			$	(87,106,163	)		$	6,136,668

 

		Series B Preferred Stock								Common Stock
		Number of Shares				Par Value				Number of Shares				Par Value				Additional Paid-In-Capital				Accumulated Deficit				Total
Balance, December 31, 2022			–			$	–				506,198			$	506			$	75,585,411			$	(71,735,834	)		$	3,850,083
Exercise of restricted stock units and warrants			–				–				7,830				8				42,789				–				42,797
Share-based compensation			–				–				–				–				357,680				–				357,680
Net loss			–				–				–				–				–				(2,155,312	)			(2,155,312	)
Balance, March 31, 2023			–				–				514,028				514				75,985,880				(73,891,146	)			2,095,248
Issuance of common shares, net of costs			–				–				283,861				284				3,963,600				–				3,963,884
Issuance of warrants			–				–				–				–				383,004				–				383,004
Share-based compensation			–				–				–				–				224,856				–				224,856
Revaluation of share-based compensation liability			–				–				–				–				(12,352	)			–				(12,352	)
Net loss			–				–				–				–				–				(2,322,862	)			(2,322,862	)
Balance, June 30, 2023			–				–				797,888				798				80,544,988				(76,214,008	)			4,331,778
Share-based compensation			–				–				–				–				217,141				–				217,141
Revaluation of share-based compensation			–				–				–				–				(17,424	)			–				(17,424	)
Net loss			–				–				–				–				–				(2,116,482	)			(2,116,482	)
Balance, September 30, 2023			–			$	–				797,888			$	798			$	80,744,705			$	(78,330,490	)		$	2,415,013

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 

 

 

Auddia Inc.

Condensed Statements of Cash Flows

(Unaudited)

 

		Nine Months Ended September 30,
		2024				2023
Cash flows from operating activities:
Net loss		$	(6,460,181	)		$	(6,594,656	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Finance charge associated with debt issuance cost			–				850,688
Depreciation and amortization			1,473,089				1,350,820
Share-based compensation expense			425,193				799,677
Change in fair value of warrants			632,388				–
Amortization of ROU asset			13,925				–
Change in assets and liabilities:
Accounts receivable			203				(437	)
Prepaid assets			(13,215	)			(56,705	)
Other current assets			(2,889	)			4,390
Accounts payable and accrued liabilities			136,447				241,269
Lease liabilities			(8,284	)			–
Net cash used in operating activities			(3,803,324	)			(3,404,954	)
Cash flows from investing activities:
Purchase of property and equipment			(12,199	)			–
Software capitalization			(787,336	)			(743,208	)
Net cash used in investing activities			(799,535	)			(743,208	)
Cash flows from financing activities:
Offering costs in connection with the issuance of preferred shares			(72,807	)			–
Net settlement of share-based compensation liability			(19,686	)			(80,115	)
Proceeds from related party debt, net of original issue discount			–				750,000
Repayments of related party debt			(2,750,000	)			–
Proceeds from issuance of preferred shares, net of issuance costs			2,238,575				–
Proceeds from issuance of common shares, net of issuance costs			8,176,048				4,016,521
Net cash provided by financing activities			7,572,130				4,686,406
Net decrease in cash			2,969,271				538,244
Cash, beginning of year			804,556				1,661,434
Cash and restricted cash, end of period		$	3,773,827			$	2,199,678
Supplemental disclosures of cash flow information:
Cash paid for interest		$	1,045			$	6,000
Cash paid for taxes		$	–			$	–
Supplemental disclosures of non-cash activity:
Reclassification of deferred offering costs		$	134,354			$	52,637
Capitalized dividends		$	102,652			$	–
Original issue discount and issuance of warrants on related party debt		$	–			$	458,004
Issuance of warrants in connection with related party notes		$	911,384			$	–
Right of use asset and assumption of operating lease liability		$	95,311			$	–

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 

 

Auddia Inc.

Notes to Condensed Financial Statements (Unaudited)

 

 

Note 1 – Description of Business, Basis of Presentation and Summary of Significant Accounting Policies

 

Description of Business

 

Auddia Inc., (the “Company”, “Auddia”, “we”, “our”) is a technology company that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company is incorporated in Delaware and headquartered in Colorado.

 

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”).

 

Interim Financial Information

 

The condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. The condensed balance sheet as of December 31, 2023 has been derived from the financial statements included in the Company’s annual report on Form 10-K. Accordingly, these condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K. The results for any interim period are not necessarily indicative of results for any future period. The Company recorded all adjustments necessary for a fair statement of the results for the interim period and all such adjustments are of a normal recurring nature.

 

Reverse Stock Split

 

The Company filed an amendment to its Certificate of Incorporation with the Secretary of State in Delaware which became effective as of 5:00 P.M. Eastern Time on February 26, 2024. As a result, every twenty-five (25) issued shares of common stock were automatically combined into one share of common stock.

 

Shares of the Company’s common stock were assigned a new CUSIP number (05072K 206) and began trading on a split-adjusted basis on February 27, 2024.

 

The reverse stock split did not change the authorized number of shares of the Company’s common stock. No fractional shares were issued and any fractional shares resulting from the reverse stock split were rounded up to the nearest whole share. Therefore, stockholders with less than 25 shares received one share of stock.

 

All stock amounts have been retrospectively adjusted to account for the reverse stock split. The reverse stock split applies to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable were adjusted proportionately as a result of the reverse stock split. The exercise prices of any outstanding warrants or stock options were also proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans.

 

 

 

8

 

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

The condensed financial statements include some amounts that are based on management’s best estimates and judgments. The most significant estimates relate to valuation of capital stock, warrants and options to purchase shares of the Company’s common stock, and the estimated recoverability and amortization period for capitalized software development costs. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.

 

Risks and Uncertainties

 

The Company is subject to various risks and uncertainties frequently encountered by companies in the early stages of development. Such risks and uncertainties include, but are not limited to, its limited operating history, competition from other companies, limited access to additional funds, dependence on key personnel, and management of potential rapid growth. To address these risks, the Company must, among other things, develop its customer base; implement and successfully execute its business and marketing strategy; develop follow-on products; provide superior customer service; and attract, retain, and motivate qualified personnel. There can be no guarantee that the Company will be successful in addressing these or other such risks.

 

Emerging Growth Company Status

 

The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period to comply with certain new or revised accounting standards that have different effective dates for public and private companies.

 

Going Concern

 

The Company had cash and cash equivalents of $3,773,827 as of September 30, 2024. The Company will need additional funding to complete the development of the full product line and scale products with a demonstrated market fit. The Company raised an additional $10.4 million during 2024 and paid down $2.75 million in Secured Bridge Notes and will only be sufficient to fund our current operating plans into the first quarter of 2025. Management has plans to secure such additional funding. If the Company is unable to raise capital when needed or on acceptable terms, the Company will be forced to delay, reduce, or eliminate technology development and commercialization efforts.

 

As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. Management has plans to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern, such as the White Lion equity line of credit (refer to Note 7) and additional future financing agreements. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s current level of cash is not sufficient to execute the business plan. For the foreseeable future, the Company will incur significant operating expenses, capital expenditures and working capital funding that will deplete cash on hand during the first quarter of 2025.

 

 

 

9

 

 

Cash and Cash Equivalents

 

The Company had cash on hand of $3,770,855 and $801,448 as of September 30, 2024 and December 31, 2023, respectively.

 

The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company had cash equivalents of $2,972 and $3,108 as of September 30, 2024 and December 31, 2023, respectively.

 

The Company maintains cash deposits at several financial institutions, which are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. As of September 30, 2024, the Company had approximately $3.5 million in excess of federally insured limits. As of December 31, 2023, the Company had approximately $0.6 million in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests.

 

Software Development Costs

 

The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable.

 

The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies.

 

Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are considered impaired and expensed during the period of such determination. The Company determined that no such impairments were required during the three and nine months ended September 30, 2024 and 2023. Software development costs of $258,734 and $213,705 were capitalized for the three months ended September 30, 2024 and 2023, respectively. Software development costs of $787,336 and $743,208 were capitalized for the nine months ended September 30, 2024 and 2023, respectively. Amortization of capitalized software development costs was $492,872 and $458,973 for the three months ended September 30, 2024, and 2023, respectively and $1,456,554 and $1,331,823 for the nine months ended September 30, 2024 and 2023, respectively, and is included in depreciation and amortization expense in the Company’s condensed statement of operations.

 

Revenue Recognition

 

Revenue will be measured according to Accounting Standards Codification (“ASC”) 606, Revenue – Revenue from Contracts with Customers, and will be recognized based on consideration specified in a contract with a customer, and excludes any sales incentives and amounts collected on behalf of third parties. The Company will recognize revenue when a performance obligation is satisfied by transferring control over a service or product to a customer. The Company will report revenues net of any tax assessed by a governmental authority that is both imposed on, and concurrent with, a specific revenue-producing transaction between a seller and a customer in the condensed statements of operations. Collected taxes will be recorded within Other current liabilities until remitted to the relevant taxing authority.

 

 

 

10

 

 

Subscriber revenue will consist primarily of subscription fees and other ancillary subscription-based revenues. Revenue will be recognized on a straight-line basis when the performance obligations to provide each service for the period are satisfied, which is over time as our subscription services are continuously available and can be consumed by customers at any time. There is no revenue recognized for unpaid trial subscriptions.

 

Customers may pay for the services in advance of the performance obligation and therefore these prepayments would be recorded as deferred revenue. The deferred revenue will be recognized as revenue in the statement of operations as the services are provided.

 

Share-Based Compensation

 

The Company accounts for share-based compensation arrangements with employees, directors, and consultants and recognizes the compensation expense for share-based awards based on the estimated fair value of the awards on the date of grant in accordance with ASC 718.

 

Compensation expense for all share-based awards is based on the estimated grant-date fair value and recognized in earnings over the requisite service period (generally the vesting period). The Company records share-based compensation expense related to non-employees over the related service periods.

 

Certain share-based compensation awards include a net-share settlement feature that provides the grantee an option to withhold shares to satisfy tax withholding requirements and are classified as a share-based compensation liability. Cash paid to satisfy tax withholdings is classified as financing activities in the condensed statements of cash flows.

 

Warrants

 

The Company account for warrants as equity-classified instruments, based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

In connection with the amendment to the Secured Bridge Notes (see Note 4), the Company converted $911,384, consisting of accrued interest and the original issue discount on the Bridge Notes, into equity securities. As a result of the conversion, the Company recognized a change in the fair value of warrants in the amount of $0 and $632,388 during the three and nine months ended September 30, 2024.

 

Reclassifications

 

Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not have an impact on net loss as previously reported.

 

 

 

11

 

 

Note 2 – Property & Equipment, Intangible Assets, and Software Development Costs

 

Property and equipment and software development costs consisted of the following as of:

Schedule of property and equipment and software development costs
		September 30, 2024				December 31, 2023
Computers and equipment		$	110,551			$	102,348
Furniture			11,258				7,263
Accumulated depreciation			(107,581	)			(91,512	)
Total property and equipment, net		$	14,228			$	18,099
Domain name		$	3,947			$	3,947
Accumulated amortization			(465	)			–
Total intangible assets, net		$	3,482			$	3,947
Software development costs		$	8,442,542			$	7,655,206
Accumulated amortization			(5,763,826	)			(4,307,271	)
Total software development costs, net		$	2,678,716			$	3,347,935

 

The Company recognized depreciation expense of $3,291 and $6,193 for the three months ended September 30, 2024 and 2023, respectively related to property and equipment, amortization expense of $202 and $0 for the three months ended September 30, 2024 and 2023, respectively related to intangible assets, and amortization expense of $492,872 and $458,973 for the three months ended September 30, 2024 and 2023, respectively related to software development costs. The Company recognized depreciation expense of $16,069 and $18,997 for the nine months ended September 30, 2024 and 2023, respectively related to property and equipment, amortization expense of $465 and $0 for the nine months ended September 30, 2024 and 2023, respectively related to intangible assets, and amortization expense of $1,456,554 and $1,331,823 for the nine months ended September 30, 2024 and 2023, respectively related to software development costs.

 

Note 3 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consist of the following:

Schedule of accounts payable and accrued liabilities
		September 30, 2024				December 31, 2023
Accounts payable and accrued liabilities		$	434,986			$	424,510
Credit cards payable			6,740				16,975
Accrued interest			–				470,179
Total accounts payable and accrued liabilities		$	441,726			$	911,664

 

 

 

12

 

 

Note 4 – Notes Payable to Related Party, net of debt issuance costs

 

During November 2022, the Company entered into a Secured Bridge Note (the “Prior Note”) financing with an accredited investor and existing shareholder of the Company. The Prior Note had a principal amount of $2,200,000, including an original issue discount of $200,000. The Prior Note bore interest at an annual stated interest rate of 10% with an original maturity date of May of 2023. The Prior Note is secured by a lien on substantially all of the Company’s assets. At maturity, the lender had the option to convert the original issue discount and accrued but unpaid interest into shares of the Company’s common stock at a fixed conversion price of $30.75 per share. The conversion option was available to the lender at the earlier of (i) maturity, or (ii) payback of all the principal. The embedded conversion option was not accounted for separately, in accordance with the guidance outlined in ASC 815-40, as it was considered indexed to the Company’s shares. The Company had the option to extend the maturity date by six months to November 2023. In the event of an extension, the Company will issue additional warrants, and the interest rate on the Note will increase to 20%.

 

In connection with the Prior Note financing, the Company issued 12,000 common stock warrants with a five-year term at an exercise price of $52.50 per share. At the time of issuance, the common stock warrants were valued at $361,878 and recorded as a debt discount to the Prior Note. The issued common stock warrants were classified as equity as they were indexed to the Company’s shares in accordance with ASC 815-40.

 

During April 2023, the Company entered into an additional Secured Bridge Note (the “New Note”) financing with the same accredited investor and significant existing shareholder. The New Note had a principal amount of $825,000, including an original issue discount of $75,000. The New Note bore interest at an annual stated interest rate of 10% with an original maturity date of July 2023. The New Note is secured by a lien on substantially all of the Company’s assets. At maturity, the lender had the option to convert the original issue discount and accrued but unpaid interest into shares of the Company’s common stock at a fixed conversion price of $52.50 per share. The conversion option was available to the lender at the earlier of (i) maturity, or (ii) payback of all the principal. The embedded conversion option was not accounted for separately, in accordance with the guidance outlined in ASC 815-40, as it was considered indexed to the Company’s shares.

 

In connection with the New Note financing, the Company issued 26,000 common stock warrants with a five-year term at an exercise price of $52.50 per share, from which 13,000 common stock warrants were exercisable immediately and were exercisable in the event that the loan term is extended. At the time of issuance, the common stock warrants were valued at $252,940, which was recorded as an additional debt discount to the New Note. The issued common stock warrants were classified as equity as they were indexed to the Company’s shares in accordance with ASC 815-40.

 

During April 2023, the Company also modified the terms of the Prior Note and cancelled the original 12,000 common stock warrants issued with the Prior Note. The Company recognized the modification in accordance with ASC 815-40-35, which resulted in the recognition of debt discount in the amount of $35,981. In lieu of the cancelled common stock warrants, the Company issued 24,000 new common stock warrants with a five-year term at an exercise price of $52.50 per share. From the newly issued 24,000 new common stock warrants, 12,000 common stock warrants were fully vested and immediately exercisable, while the remaining 12,000 common stock warrants remained unvested. The issued common stock warrants were classified as equity as they were indexed to the Company’s shares in accordance with ASC 815-40.

 

In May of 2023, the Company renegotiated with the lender an extension of the maturity date of the Prior Note for six months to November 2023 with an increased annual interest rate of 20% and issued an additional 12,000 common stock warrants to the lender. The additional common stock warrants were valued at $94,083 and recorded as an additional debt discount. The issued common stock warrants were classified in equity as they were considered indexed to the Company’s shares in accordance with ASC 815-40. In connection with this extension, the 12,000 outstanding unvested warrants became vested and exercisable.

 

On July 31, 2023, the Company extended the maturity date of the New Note to November 30, 2023. In connection with such extension, 13,000 outstanding unvested common stock warrants became vested and exercisable. There was no change in the application of the accounting under ASC 815-40.

 

 

 

13

 

 

As of September 30, 2024 and December 31, 2023, the balance of the Prior Note, net of debt issuance costs, was $0 and $2,200,000, respectively. Interest expense related to the Prior Note, including interest incurred, amortization of the debt discount, and the warrant amortization for the three months ended September 30, 2024 and 2023 was $0 and $157,298, respectively. Interest expense related to the Prior Note, including interest incurred, amortization of the debt discount, and the warrant amortization for the nine months ended September 30, 2024 and 2023 was $121,000 and $762,112, respectively. As of September 30, 2024 and December 31, 2023, the balance of the New Note issued in April 2023, net of debt issuance costs, was $0 and $825,000 respectively. Interest expense related to the New Note, including interest incurred, amortization of the debt discount, and the warrant amortization for the three months ended September 30, 2024 and 2023 was $0 and $401,441. Interest expense related to the New Note, including interest incurred, amortization of the debt discount, and the warrant amortization for the nine months ended September 30, 2024 and 2023 was $45,205 and 401,441.

 

On April 9, 2024, the Company and the investor entered into an Amendment and Waiver Agreement relating to the Bridge Notes.

  

The Company agreed to pay $2.75 million in cash to the Investor in repayment of the principal of the Bridge Notes (exclusive of the $275,000 of original issue discount on the Bridge Notes) shortly after the closing by the Company of one or more equity financings with total gross proceeds to the Company of not less than $6,000,000.

 

On April 26, 2024, the Company repaid $2.75 million of principal on its Secured Bridge Notes.

 

Effective April 9, 2024, the Investor converted $911,384 (the “Rollover Amount”) which is equal to the (i) unpaid accrued interest on the Bridge Notes plus (ii) the original issue discount (“OID”) on the Bridge Notes, into equity securities of the Company (the “Rollover Securities”).

 

The Rollover Securities consist of (i) 463,337 prefunded common stock warrants with a per share exercise price of $0.001 per share (the “Prefunded Warrants”) and (ii) 463,337 non-prefunded warrants (the “Non-Prefunded Warrants”) with a per share exercise price equal to $1.967. As of the date and time of the Amendment and Waiver Agreement, the Nasdaq Minimum Price (as defined in the applicable Nasdaq listing rules) for the Company’s common stock was $1.966.

 

The number of Prefunded Warrants was determined by dividing the Rollover Amount by $1.967. The number of Non-Prefunded Warrants is equal to the number of Prefunded Warrants (i.e. 100% warrant coverage). The Non-Prefunded Warrants have a price adjustment provision which will adjust the exercise price downward in the event that the Company issues equity securities in the future at an effective per share price below the then current exercise price. In order to assure compliance with applicable Nasdaq rules, the Non-Prefunded Warrants shall not be exercisable for six months following the date of issue.

 

The Company issued to the Investor 50,000 new common stock warrants with a five-year term as a loan extension fee (“Fee Warrants”). The exercise price of these additional Fee Warrants is $1.967. The Fee Warrants have a price adjustment provision which will adjust the exercise price downward in the event that the Company issues equity securities in the future at an effective per share price below the then current exercise price. In order to assure compliance with applicable Nasdaq rules, the Fee Warrants shall not be exercisable for six months following the date of issue.

 

The Non-Prefunded Warrants and Fee Warrants had a total valuation of $811,402 and the Prefunded Warrants had a valuation of $732,370. As a result, the Company recorded $911,384 as a non-cash charge in connection with the issuance of warrants related to the Secured Bridge Notes and a change in the fair value of warrants of $632,388, which is included in other expense in the accompanying statements of operations. All Warrants were classified as equity as they were indexed to the Company’s shares in accordance with ASC 815-40.

 

The Company agreed to adjust the exercise price of the Investor’s Existing Warrants from $15.25 (after adjustment for the recent reverse stock) to $1.967 per share.

 

The Investor will not be able to receive shares upon exercise of any of the foregoing securities, unless prior stockholder approval is obtained, if (i) the number of shares to be issued would exceed 20% of the Company’s outstanding number of shares at a discount to the applicable Nasdaq Minimum Price or (ii) the number of shares to be issued would result in in a Change of Control within the meaning of Nasdaq Rule 5635(b).

 

 

 

14

 

 

Note 5 – Commitments and Contingencies

 

Operating Lease

 

On March 25, 2024, the Company entered into a new 37-month operating lease commencing on April 1, 2024 with two separate two year renewal options. The monthly base rent for months two through 14 is $2,456, increasing to $3,070 for months 15 through 26, and ending at $3,684 for months 27 through 37. Rent expense, as part of general and administrative expenses in the condensed statement of operations, was $8,960 and $22,721 for the three and nine months ended September 30, 2024, respectively, which consisted of the new lease and a temporary month-to-month lease the Company entered into until a long-term space was identified. Rent expense was $12,053 and $49,491 for the three and nine months ended September 30, 2023, respectively, under the former lease that terminated in December 2023.

 

Litigation

 

In the normal course of business, the Company is party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company. There are no active litigations as of the date the financial statements were issued. However, a pre-IPO investor has contacted the Company claiming damages caused by alleged acts and omissions arising from a private financing by the Company. No complaint has been filed by the investor. The alleged damages asserted by the investor are less than approximately $300,000. The outcome of the complaint was neither probable or estimable as of the date the financial statements were issued, therefore, no accrual has been made.

 

NASDAQ Deficiencies

 

On November 21, 2023, the Company received a written notice from Nasdaq indicating that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Equity Requirement”). In the Company’s quarterly report on Form 10-Q for the period ended September 30, 2023, the Company reported stockholders’ equity of $2,415,012, and, as a result, did not satisfy Listing Rule 5550(b)(1). Nasdaq’s November written notice had no immediate impact on the listing of our common stock. The hearing with the Panel occurred on January 18, 2024, and addressed all outstanding listing compliance matters, including compliance with the Stockholders’ Equity Notice as well as compliance with the Bid Price Requirement.

 

On January 30, 2024, the Panel granted the Company’s request for an exception to Nasdaq’s listing rules until April 22, 2024, to demonstrate compliance with all applicable continued listing requirements for the Nasdaq Capital Market.

 

On April 16, 2024, the Company received a letter from Nasdaq granting an exception to the Exchange’s listing rules until May 20, 2024, to demonstrate compliance with Listing Rule 5550(b)(1) (the “Equity Rule”).

 

On May 24, 2024, the Company received a letter from Nasdaq indicating that the Company has regained compliance with the equity requirement in Listing rule 5550(b) (1) (the Equity Rule”.) The Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of the letter in accordance with application of Listing Rule 5815(d)(4)(B).

 

The Nasdaq listing rules require listed securities to maintain a minimum bid price of $1.00 per share. On October 16, 2024, the Company received a written notice from Nasdaq indicating that it was not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing. The Bid Price Notice does not result in the immediate delisting of the Company’s common stock from the Nasdaq Capital Market. The Bid Price Notice indicated that the Company has 180 calendar days (or until April 14, 2025) in which to regain compliance.

 

The Company’s receipt of these Nasdaq letters does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.

 

 

 

15

 

 

Note 6 – Share-based Issuances

 

Stock Options

 

The following table presents the activity for stock options outstanding:

Schedule of activity for stock options outstanding
		Options				Weighted Average Exercise Price
Outstanding - December 31, 2023			84,895			$	47.79
Granted			–				–
Forfeited/canceled			(1,147	)			55.63
Exercised			–				–
Outstanding – September 30, 2024			83,748			$	47.69

 

		Options				Weighted Average Exercise Price
Outstanding - December 31, 2022			66,527			$	61.25
Granted			8,008				23.50
Forfeited/canceled			(8,258	)			37.75
Exercised			–				–
Outstanding – September 30, 2023			66,277			$	59.50

 

The following table presents the composition of options outstanding and exercisable:

Schedule of options outstanding and exercisable
		Options Outstanding**												Options Exercisable**
Exercise Prices		Number				Price				Life*				Number				Price*
$67.56			346			$	67.56				0.04				346			$	67.56
$72.39			2,131			$	72.39				3.11				2,131			$	72.39
$106.50			6,853			$	106.50				4.73				6,853			$	106.50
$69.75			30,891			$	69.75				6.23				29,041			$	69.75
$44.75			7,250			$	44.75				6.93				4,175			$	44.75
$30.25			15,577			$	30.25				7.95				15,577			$	30.25
$9.90			2,000			$	9.90				8.69				500			$	9.90
$6.25			18,700			$	6.25				9.21				–			$	6.25
Total – September 30, 2024			83,748												58,623

 

*	Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.
**	The Company’s options summarized above have been retroactively restated for the effect of the 25-for-1 reverse stock split.

 

 

 

16

 

 

Restricted Stock Units

 

The following table presents the activity for restricted stock units outstanding:

Schedule of activity for restricted stock units outstanding
		Restricted Stock Units				Weighted Average Grant Date Fair Value
Outstanding - December 31, 2023			11,490			$	59.36
Granted			–				–
Forfeited/canceled			–				–
Vested/issued			(6,245	)			61.74
Outstanding – September 30, 2024			5,245			$	56.52

 

		Restricted Stock Units				Weighted Average Grant Date Fair Value
Outstanding - December 31, 2022			22,554			$	53.50
Granted			1,500				31.00
Forfeited/canceled			(4,734	)			45.75
Vested/issued			(7,830	)			45.75
Outstanding – September 30, 2023			11,490			$	59.25

 

The Company recognized share-based compensation expense related to stock options and restricted stock units of $119,416 and $217,141 for the three months ended September 30, 2024 and 2023, respectively, and $425,193 and $799,677 for the nine months ended September 30, 2024 and 2023, respectively. The remaining unvested share-based compensation expense of $295,304 is expected to be recognized over the next 39 months.

 

Note 7 – Equity Financings

 

Equity Line Sales of Common Stock

 

On November 14, 2022, the Company entered into a Common Stock Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC, a Nevada limited liability company (“White Lion”) for an equity line facility.

 

In April and June 2023, the Company closed on three sales of Common Stock under the White Lion Purchase Agreement. As a result, the Company issued an aggregate of 2,361,514 common shares and received aggregate proceeds of approximately $1.3 million.

 

Any proceeds that the Company receives under the White Lion Purchase Agreement are expected to be used for working capital and general corporate purposes.

 

The White Lion Purchase Agreement prohibits the Company from issuing and selling any shares of common stock to White Lion to the extent such shares, when aggregated with all other shares of our common stock then beneficially owned by White Lion, would cause White Lion’s beneficial ownership of common stock to exceed 9.99% (the “Beneficial Ownership Cap”).

 

 

 

17

 

 

The Company recognized all offering costs related to the equity line of credit as deferred offering costs in accordance with the guidance in ASC 835-30-S45.

 

Replacement Equity Line with White Lion

 

On November 6, 2023, the Company entered into a new Common Stock Purchase Agreement and a related registration rights agreement with White Lion. Pursuant to the new Common Stock Purchase Agreement, the Company has the right, but not the obligation to require White Lion to purchase, from time to time until December 31, 2024, up to $10,000,000 in aggregate gross purchase price of newly issued shares of the Company’s common stock, subject to certain limitations and conditions set forth in the Common Stock Purchase Agreement. In connection with the new Common Stock Purchase Agreement, the parties agreed to terminate the previous Common Stock Purchase Agreement with White Lion.

 

During the nine months ended September 30, 2024, the Company closed on several sales of Common Stock under the White Lion Purchase Agreement. As a result, the Company issued an aggregate of 4,815,263 common shares and received aggregate proceeds of approximately $8.2 million.

 

$2.3 Million Convertible Preferred Stock and Warrants Financing

 

On April 23, 2024, the Company entered into a securities purchase agreement with accredited investors for a convertible preferred stock and warrants financing. The Company received $2,314,000 of gross proceeds in connection with the closing of this financing.

 

At the closing, the Company issued 2,314 shares of Series B convertible preferred stock (“Series B Preferred Stock”) at a purchase price of $1,000 per share of Series B Preferred Stock. The Series B Preferred Stock is convertible into Common Stock at an initial conversion price (“Conversion Price”) of $1.851 per share of Common Stock. The Company also issued warrants (“Warrants”) exercisable for 1,250,137 shares of Common Stock with a five-year term and an initial exercise price of $1.851 per share.

 

The proceeds of this financing, together with other available cash resources, were used to repay outstanding debt and for general corporate purposes.

 

Holders of the Series B Preferred Stock will be entitled to dividends in the amount of 10% per annum, payable quarterly. The Company has the option to pay dividends on the Series B Preferred Stock in additional shares of Common Stock. The Company also has the option to cumulate or “capitalize” the dividends, in which case the accrued dividend amount shall be added to the stated value of each share of Series B Preferred Stock. As of September 30, 2024, the Company has elected to capitalize all dividends declared.

  

Warrants

 

The following table presents the activity for warrants outstanding:

Schedule of activity for warrants outstanding
		Warrants				Weighted Average Exercise Price
Outstanding - December 31, 2023			216,884			$	96.00
Granted			2,226,811				1.85
Forfeited/cancelled/restored			(14,154	)			–
Exercised			–				–
Outstanding – September 30, 2024			2,429,541			$	15.00

 

 

 

18

 

 

Note 8 – Leases under ASC 842

 

The Company leases certain office space under operating leases for use in operations. The Company recognizes operating lease expense on a straight-line basis over the lease term. Management determines if an arrangement is a lease at contract inception. Lease and non-lease components are accounted for as a single component for all leases. Operating lease right to use (“ROU”) assets and liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the expected lease term, which includes optional renewal periods if the Company determines it is reasonably certain that the option will be exercised. As the operating lease does not provide an implicit rate, the discount rate used in the present value calculation represents the incremental borrowing rate determined using information available at the commencement date. For the three and nine months ended September 30, 2024, the Company recorded operating lease expense of $8,960 and $17,921, respectively, which is included in general and administrative expenses in the Company’s accompanying condensed statements of operations. As of September 30, 2024, weighted-average remaining lease term and discount rate were as follows:

Schedule of weighted-average remaining lease term and discount rate
		September 30, 2024
Weighted-average remaining lease term			4.8 years
Weighted-average discount rate			8.6%

 

The following is a maturity analysis of the annual undiscounted cash flows reconciled to the carrying value of the operating lease liabilities as of September 30, 2024:

Schedule of annual undiscounted cash flows of leases
Years Ended December 31,
2024		$	7,367
2025			34,382
2026			41,749
2027			14,735
Less imputed interest			(11,205	)
Total		$	87,028

 

Note 9 – Subsequent Events

 

Management evaluated subsequent events and transactions that occurred after the balance sheet date, up to the date that the financial statements were issued. Based upon this review, other than as set forth below, management did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

 

The Nasdaq listing rules require listed securities to maintain a minimum bid price of $1.00 per share. On October 16, 2024, the Company received a written notice from Nasdaq indicating that it was not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing. The Bid Price Notice does not result in the immediate delisting of the Company’s common stock from the Nasdaq Capital Market. The Bid Price Notice indicated that the Company has 180 calendar days (or until April 14, 2025) in which to regain compliance.

 

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis should be read in conjunction with the unaudited condensed financial statements and related notes included elsewhere in this Quarterly Report and our audited financial statements and related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on April 1, 2024. This discussion and analysis and other parts of this Quarterly Report contain forward-looking statements based upon current beliefs, plans and expectations that involve risks, uncertainties and assumptions, such as statements regarding our plans, objectives, expectations, intentions and projections. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under Part II, Item 1A, “Risk Factors” and elsewhere in this Quarterly Report. You should carefully read the “Risk Factors” section of this Quarterly Report and of our Annual Report on Form 10-K for the year ended December 31, 2023, to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section entitled “Special Note Regarding Forward-Looking Statements.”

 

Overview

 

Auddia is a technology company headquartered in Boulder, CO that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. Auddia is leveraging these technologies within its industry-first audio Superapp, faidr (previously known as the Auddia App).

 

faidr gives consumers the opportunity to listen to any AM/FM radio station with commercial breaks replaced with personalized audio content, including popular and new music, news, and weather. The faidr app represents the first-time consumers can combine the local content uniquely provided by AM/FM radio with commercial-free and personalized listening many consumers demand from digital-media consumption. In addition to commercial-free AM/FM, faidr includes podcasts – also with ads removed or easily skipped by listeners – as well as exclusive content, branded faidrRadio, which includes new artist discovery, curated music stations, and Music Casts. Music Casts are unique to faidr. Hosts and DJs can combine on-demand talk segments with dynamic music streaming, which allows users to hear podcasts with full music track plays embedded in the episodes.

 

Auddia has also developed a differentiated podcasting capability with ad-reduction features and also provides a unique suite of tools that helps podcasters create additional digital content for their podcast episodes as well as plan their episodes, build their brand, and monetize their content with new content distribution channels. This podcasting feature also gives users the ability to go deeper into the stories through supplemental, digital content, and eventually comment and contribute their own content to episode feeds.

 

The combination of AM/FM streaming and podcasting, with Auddia’s unique, technology-driven differentiators, addresses large and rapidly growing audiences.

 

We have developed our AI platform on top of Google’s TensorFlow open-source library that is being “taught” to know the difference between all types of audio content on the radio. For instance, the platform recognizes the difference between a commercial and a song and is learning the differences between all other content to include weather reports, traffic, news, sports, DJ conversation, etc. Not only does the technology learn the differences between the various types of audio segments, but it also identifies the beginning and end of each piece of content.

 

We are leveraging this technology platform within our premium AM/FM radio listening experience through the faidr App. The faidr App is intended to be downloaded by consumers who will pay a subscription fee in order to listen to any streaming AM/FM radio station and podcasts, all with commercial interruptions removed from the listening experience, in addition to the faidrRadio exclusive content offerings. Advanced features will allow consumers to skip any content heard on the station and request audio content on-demand. We believe the faidr App represents a significant differentiated audio streaming product, or Superapp, that will be the first to come to market since the emergence of popular streaming music apps such as Pandora, Spotify, Apple Music, Amazon Music, etc.  We believe that the most significant point of differentiation is that in addition to ad-free AM/FM streaming and ad-reduced podcasts, the faidr App is intended to deliver non-music content that includes local sports, news, weather, traffic and the discovery of new music alongside exclusive programming. No other audio streaming app available today, including category leaders like TuneIn, iHeart, and Audacy, can compete with faidr’s full product offerings.

 

 

 

 

We launched an MVP version of faidr through several consumer trials in 2021 to measure consumer interest and engagement with the App. The full app launched on February 15, 2022, and included all major U.S. radio stations in the US. In February 2023, we added faidrRadio, our exclusive content offerings, to the app. Podcasts were added to the app for the iOS version before the end of Q1 2023 as planned and added to the Android app in May of 2023.

 

We also developed a testbed differentiated podcasting capability called Vodacast, which leveraged technologies and proven product concepts to differentiate its podcasts offering from other competitors in the radio-streaming product category.

 

With podcasting growing and predicted to grow at a rapid rate, the Vodacast podcast platform was conceptualized to fill a void in the emerging audio media space. The platform was built to become the preferred podcasting solution for podcasters by enabling them to deliver digital content feeds that match the audio of their podcast episodes, and by enabling podcasters to make additional revenue from new digital advertising channels, subscription channels, on-demand fees for exclusive content, and through direct donations from their listeners.

 

Throughout 2023 and 2024, Auddia has been migrating their podcasting capabilities into the flagship faidr app bringing the advanced podcasting functionality from Vodacast into faidr as part of the overall strategy to build a single audio Superapp. In July 2024, Auddia sunsetted the Vodacast app. Podcast functionality continues to be developed in faidr and in August 2024, we released our Forward+ and Chapter Visualization into our differentiated AI Podcast Player which delivers ad-reduction controls to a listener.

 

Today, podcasters do not have a preference as to where their listeners access their episodes, as virtually all listening options (mobile apps and web players) deliver only their podcast audio. By creating significant differentiation on which they can make net new and higher margin revenue, we believe that podcasters will promote faidr to their listeners, thus creating a powerful, organic marketing dynamic.

 

One innovative and proprietary part of Auddia’s podcast capabilities, originally presented on their Vodacast differentiated podcasting capability, is the availability of tools to create and distribute an interactive digital feed, which supplements podcast episode audio with additional digital. These content feeds allow podcasters to tell deeper stories to their listeners while giving podcasters access to digital revenue for the first time. Podcasters will be able to build these interactive feeds using The Podcast Hub, a content management system that was originally developed and trialed as part of Auddia’s Vodacast platform, which also serves as a tool to plan and manage podcast episodes. The digital feed activates a new digital ad channel that turns every audio ad into a direct-response, relevant-to-the-story, digital ad, increasing the effectiveness and value of their established audio ad model. The feed also presents a richer listening experience, as any element of a podcast episode can be supplemented with images, videos, text and web links. This feed will appear fully synchronized in the faidr mobile App, and it also can be hosted and accessed independently (e.g., through any browser), making the content feed universally distributable.

 

Over time, users will be able to comment, and podcasters will be able to grant some users publishing rights to add content directly into the feed on their behalf. This will create another first for podcasting, a dialog between creator and fan, synchronized to the episode content. The interactive feed for podcasts has been developed and tested on Vodacast and is expected to be another differentiator added into faidr for podcast listeners later in 2025.

 

The podcast capabilities within faidr will also introduce a unique and industry first multi-channel, highly flexible set of revenue channels that podcasters can activate in combination to allow listeners to choose how they want to consume and pay for content. “Flex Revenue” allows podcasters to continue to run their standard audio ad model and complement those ads with direct response enabled digital ads in each episode content feed, increasing the value of advertising on any podcast. “Flex Revenue” will also activate subscriptions, on-demand fees for content (e.g., listen without audio ads for a micro payment fee) and direct donations from listeners. Using these channels in combination, podcasters can maximize revenue generation and exercise higher margin monetization models, beyond basic audio advertising. “Flex Revenue” and the initial inclusion of the new revenue channels that come with it will be added to podcasting in the faidr app, and the first elements of this new monetization capability is expected to be commercially available in 2025, beginning with subscription plans to access ad-reduction in podcasts.

 

The faidr mobile App is available today through the iOS and Android App stores.

 

 

 

 

We have funded our operations with proceeds from the February 2021 IPO, Series A warrants exercised in July 2021 and common share issuance during June of 2023. We obtained debt financing through a related party during November 2022 and April 2023. We sold common shares during April 2023, June 2023, and during the first and second quarters of 2024 pursuant to our equity line facility. Lastly, we entered into a securities purchase agreement with accredited investors for convertible preferred stock and warrants financing. Since our inception, we have incurred significant operating losses. As of September 30, 2024, we had an accumulated deficit of $87,003,511. Our ability to generate product revenue sufficient to achieve profitability will depend heavily on the successful development and commercialization of one or more of our Apps. We expect that our expenses and capital requirements will increase substantially in connection with our ongoing activities, particularly if and as we:

 

	·	nationally launch our faidr App and as we continue training our proprietary AI technology and make product enhancements;
	·	continue to develop and expand our technology and functionality to advance the faidr app;
	·	rollout our product on a national basis, which will include increasing our sales and marketing costs related to the promotion of our products. faidr promotion will include a combination of a) purchasing ads directly from broadcasters or b) participating broadcasters to promote without purchasing ads, but sharing a portion of subscription proceeds based on listening activity on those stations;
	·	continue to pursue and complete potential acquisitions of other companies;
	·	hire additional business development, product management, operational and marketing personnel;
	·	continue market studies of our products; and
	·	add operational and general administrative personnel which will support our product development programs, commercialization efforts and our transition to operating as a public company.

 

As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, which may include collaborations with other companies or other strategic transactions. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as and when needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our product candidates.

 

Because of the numerous risks and uncertainties associated with product development, we are unable to predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations.

 

As of September 30, 2024, we had cash and cash equivalents of $3,773,827. We secured approximately $10.4 million in additional financing during 2024. We will need additional funding to complete the development of our full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. However, if we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

 

To accelerate user acquisition, revenue, and cash flow, we have explored numerous potential acquisition targets of AM/FM streaming aggregators over the past year and a half and will continue to explore new opportunities.

 

Recent Developments

 

Mergers and Acquisitions Strategy

 

We are exploring various merger and acquisition options as part of a broader strategy which aims to scale the business more rapidly; accelerate user adoption and subscriber growth; enter new markets (international); and open new pathways toward raising capital. The overall strategy focuses on three areas: (1) acquiring users of a radio-streaming app, (2) bringing our proprietary ad-free products to the acquired userbase to generate significant subscription revenue, and (3) bringing together other differentiated features into the larger audio Superapp platform.

 

We incurred $426,572 in costs related to evaluating potential acquisitions during the nine months ended September 30, 2024.

 

 

 

 

RFM Acquisition

 

On January 26, 2024, we entered into a Purchase Agreement (the “RFM Purchase Agreement”), pursuant to which we agreed to acquire RadioFM (the “RFM Acquisition”), which is currently a component of both AppSmartz and RadioFM (partnerships under common control). The aggregate consideration for the RFM Acquisition is $13,000,000 (plus $2,000,000 in contingent consideration if certain post-close milestones are reached), in addition to the assumption of certain liabilities, as may be adjusted pursuant to the terms of the RFM Purchase Agreement.

 

In March 2024, the parties mutually agreed to terminate the RFM Purchase Agreement.

 

Nasdaq Deficiency Notices

  

On November 21, 2023, we received a written notice from Nasdaq indicating that we are not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Equity Requirement”). In our quarterly report on Form 10-Q for the period ended September 30, 2023, we reported stockholders’ equity of $2,415,012, and, as a result, did not satisfy Listing Rule 5550(b)(1). Nasdaq’s November written notice had no immediate impact on the listing of our common stock. Our hearing with the Panel occurred on January 18, 2024 and addressed all outstanding listing compliance matters, including compliance with the Stockholders’ Equity Notice as well as compliance with the Bid Price Requirement.

 

On January 30, 2024, the Panel granted the Company’s request for an exception to Nasdaq’s listing rules until April 22, 2024, to demonstrate compliance with all applicable continued listing requirements for the Nasdaq Capital Market.

 

On April 16, 2024, the Company received a letter from Nasdaq granting an exception to the Exchange’s listing rules until May 20, 2024, to demonstrate compliance with Listing Rule 5550(b)(1) (the “Equity Rule”.)

 

On May 24, 2024, we received a letter from Nasdaq indicating that we had regained compliance with the equity requirement in Listing rule 5550(b) (1) (the Equity Rule”.) We will be subject to a Mandatory Panel Monitor for a period of one year from the date of the letter in accordance with application of Listing Rule 5815(d)(4)(B).

 

The Nasdaq listing rules require listed securities to maintain a minimum bid price of $1.00 per share. On October 16, 2024, we received a written notice from Nasdaq indicating that we were not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing. The Bid Price Notice does not result in the immediate delisting of our common stock from the Nasdaq Capital Market. The Bid Price Notice indicated that we have 180 calendar days (or until April 14, 2025) in which to regain compliance.

 

Reverse Share Split

 

The Company filed an amendment to its Certificate of Incorporation with the Secretary of State in Delaware which became effective as of 5:00 P.M. Eastern Time on February 26, 2024. As a result, every twenty-five (25) issued shares of common stock were automatically combined into one share of common stock.

 

Shares of the Company’s common stock were assigned a new CUSIP number (05072K 206) and began trading on a split-adjusted basis on February 27, 2024.

 

The reverse stock split did not change the authorized number of shares of the Company’s common stock. No fractional shares were issued and any fractional shares resulting from the reverse stock split were rounded up to the nearest whole share. Therefore, stockholders with less than 25 shares received one share of stock.

 

 

 

 

The reverse stock split applied to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable were adjusted proportionately as a result of the reverse stock split. The exercise prices of any outstanding warrants or stock options were also proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans.

 

Impact of Inflation

 

We have recently experienced higher costs across our business as a result of inflation, including higher costs related to employee compensation and outside services. We expect inflation to continue to have a negative impact throughout 2024, and it is uncertain whether we will be able to offset the impact of inflationary pressures in the near term.

 

Components of our results of operations

 

Operating expenses

 

Direct costs of services

 

Direct cost of services consists primarily of costs incurred related to our technology and development of our Apps, including hosting and other technology related expenses. We expect our direct costs of services to increase in the future as we continue to develop and enhance our technology related to the faidr and podcasting Apps. 

 

Sales and marketing

 

Our sales and marketing expenses consist primarily of salaries, direct to consumer promotional spend and consulting services, all of which are related to the sales and promotion performed during the period. We expect our sales and marketing expenses to fluctuate period by period as we release new upgrades and enhancements within our Apps and look to generate revenue through customer acquisition, retention, and subscription conversion.

 

Research and development

 

Since our inception, we have focused significant resources on our research and development activities related to the software development of our technology. We account for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable. We cease capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by our management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies. Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are impaired and expensed during the period of such determination. We expect to continue to incur research and development expenses and capitalization in the future as we continue to develop and enhance our faidr and podcasting Apps.

 

General and administrative

 

Our general and administrative expenses consist primarily of salaries and related costs, including payroll taxes, benefits, stock-based compensation, and professional fees related to auditing, tax, general legal services, and consulting services. We expect our general and administrative expenses to continue to increase in the future as we right-size our operating activities and prepare for commercialization of our products and support our operations as a public company, including increased expenses related to legal, accounting, insurance, regulatory and tax-related services associated with maintaining compliance with exchange listing and Securities and Exchange Commission requirements, directors and officers liability insurance premiums and investor relations activities.

 

Other income and expense

 

The other income and expense category primarily consists of interest expense attributed to the debt and conversion features of the Notes payable to related party.

 

 

 

 

Results of operations

 

Comparison of the three months ended September 30, 2024 and 2023

 

The following table summarizes our results of operations:

 

		Three Months Ended
		September 30, 2024				September 30, 2023				Change $				Change %
Revenue		$	–			$	–				–				0.0%
Operating expenses:
Direct cost of services			54,916				43,470				11,446				26.3%
Sales and marketing			282,450				316,297				(33,847	)			-10.7%
Research and development			233,085				227,133				5,952				2.6%
General and administrative			881,439				777,496				103,943				13.4%
Depreciation and amortization			495,960				465,166				30,794				6.6%
Total operating expenses			1,947,850				1,829,562				118,288				6.5%
Loss from operations			(1,947,850	)			(1,829,562	)			(118,288	)			6.5%
Other expense:
Interest expense			(1,578	)			(286,920	)			285,342				-99.4%
Change in fair value of warrants			–				–				(0	)			100.0%
Total other expense			(1,578	)			(286,920	)			285,342				-99.5%
Loss before income taxes			(1,949,428	)			(2,116,482	)			167,054				-7.9%
Provision for income taxes			–				–				–				0.0%
Net loss		$	(1,949,428	)		$	(2,116,482	)			167,054				-7.9%

 

Revenue

 

Total revenues for the three months ended September 30, 2024 and 2023 were $0 as we continue to develop and enhance our faidr and podcasting Apps to establish new revenue streams.

 

Direct cost of services

 

Direct cost of services increased $11,446 or 26.3% from $43,470 for the three months ended September 30, 2023 compared to $54,916 for the three months ended September 30, 2024. This increase was primarily the result of an increase in hosting costs and music service costs.

 

Sales and marketing

 

Sales and marketing expenses decreased by $33,847 or (10.7%) from $316,297 for the three months ended September 30, 2023 to $282,450 for the three months ended September 30, 2024, which was primarily attributed to reduced marketing promotion costs associated with the national launch of the faidr app as the quarter was focused on ASO optimization. We expect our sales and marketing expenses to fluctuate period by period as we release new upgrades and enhancements within our faidr App and look to generate revenue through customer acquisition, retention, and subscription conversion.

 

Research and development

 

Research and development expenses increased by $5,952 or 2.6% from $227,133 for the three months ended September 30, 2023 to $233,085 for the three months ended September 30, 2024, which was primarily due to an increase in capitalized R&D expenses, partially offset by a decrease in content creator fees.

 

 

 

 

General and administrative

 

General and administrative expenses increased by $103,943 or 13.4% from $777,496 for the three months ended September 30, 2023 compared to $881,439 for the three months ended September 30, 2024. The change was primarily driven by an increase in consulting, legal, and public company fees associated with the 2024 equity offerings.

 

Depreciation and amortization

 

Depreciation and amortization expenses increased by $30,794 or 6.6% from $465,166 for the three months ended September 30, 2023 compared to $495,960 for the three months ended September 30, 2024. The increase is entirely related to the increased amortization of our faidr and podcasting Apps.

 

Other expense, net

 

Total other expenses decreased by $285,342 or (99.5%) from $286,920 for the three months ended September 30, 2023 to $1,578 for the three months ended September 30, 2024. Interest expense decreased by $285,342 due to the repayment of notes payable to related party in April 2024.

 

Comparison of the nine months ended September 30, 2024 and 2023

 

The following table summarizes our results of operations:

 

		Nine Months Ended
		September 30, 2024				September 30, 2023				Change $				Change %
Revenue		$	–			$	–				–				0.0%
Operating expenses:
Direct cost of services			153,316				130,809				22,507				17.2%
Sales and marketing			645,713				765,176				(119,463	)			-15.6%
Research and development			558,180				617,622				(59,442	)			-9.6%
General and administrative			2,826,563				2,596,831				229,732				8.8%
Depreciation and amortization			1,473,088				1,350,820				122,268				9.1%
Total operating expenses			5,656,860				5,461,258				195,602				3.6%
Loss from operations			(5,656,860	)			(5,461,258	)			(195,602	)			3.6%
Other expense:
Interest expense			(170,933	)			(1,133,398	)			962,465				-84.9%
Change in fair value of warrants			(632,388	)			–				(632,388	)			100.0%
Total other expense			(803,321	)			(1,133,398	)			330,077				-29.1%
Loss before income taxes			(6,460,181	)			(6,594,656	)			134,475				-2.0%
Provision for income taxes			–				–				–				0.0%
Net loss		$	(6,460,181	)		$	(6,594,656	)			134,475				-2.0%

 

Revenue

 

Total revenues for the nine months ended September 30, 2024 and 2023 were $0 as we continue to develop and enhance our faidr and podcasting Apps to establish new revenue streams.

 

 

 

 

Direct cost of services

 

Direct cost of services increased $22,507 or 17.2% from $130,809 for the nine months ended September 30, 2023 compared to $153,316 for the nine months ended September 30, 2024. This increase was primarily the result of an increase in hosting costs and data subscription fees.

 

Sales and marketing 

Sales and marketing expenses decreased by $119,463 or (15.6%) from $765,176 for the nine months ended September 30, 2023 to $645,713 for the nine months ended September 30, 2024, which was primarily attributed to reduced marketing promotion costs associated with the national launch of the faidr app. We expect our sales and marketing expenses to fluctuate period by period as we release new upgrades and enhancements within our Apps and look to generate revenue through customer acquisition, retention, and subscription conversion.

 

Research and development

 

Research and development expenses decreased by $59,442 or (9.6%) from $617,622 for the nine months ended September 30, 2023 to $558,180 for the nine months ended September 30, 2024, which was primarily due to lower consulting and content creator fees.

 

General and administrative

 

General and administrative expenses increased by $229,732 or 8.8% from $2,596,831 for the nine months ended September 30, 2023 compared to $2,826,563 for the nine months ended September 30, 2024. The increase was primarily driven by an increase in salary expense and professional fees to support compliance requirements related to potential acquisitions and equity offerings, partially offset by lower stock compensation expense.

 

Depreciation and amortization

 

Depreciation and amortization expenses increased by $122,268 or 9.1% from $1,350,820 for the nine months ended September 30, 2023 compared to $1,473,088 for the nine months ended September 30, 2024. The increase is entirely related to the increased amortization of our faidr and podcasting Apps.

 

Other expense, net

 

Total other expenses decreased by $330,077 or (29.1%) from $1,133,398 for the nine months ended September 30, 2023 to $803,321 for the nine months ended September 30, 2024. Interest expense decreased by $962,465 due to the repayment of notes payable to related party in April 2024. Interest expense was offset by $632,388 due to the change in the fair value of the notes payable converted to equity.

 

Liquidity and capital resources

 

Sources of liquidity

 

We have incurred operating losses since our inception and have an accumulated deficit as a result of ongoing efforts to develop and commercialize our faidr and podcasting Apps. As of September 30, 2024 and December 31, 2023, we had cash and cash equivalents of $3,773,827 and $804,556, respectively. We have working capital in the amount of approximately $3.4 million as of September 30, 2024. We anticipate that operating losses and net cash used in operating activities will increase over the next 12 months as we continue to develop and market our products. We secured $10.4 million of additional financing in 2024, which enabled us to pay down $2.75 million in connection with the Secured Bridge Notes and will only be sufficient to fund our current operating plans into the first quarter of 2025. The Company has based these estimates, however, on assumptions that may prove to be wrong. We will need additional funding to complete the development of our full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. If we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

 

 

 

 

Interim Bridge Financings

 

As previously disclosed, on November 14, 2022, we entered into a Secured Bridge Note (“Prior Note”) financing with one of our accredited investors, a significant existing shareholder of the Company. We received $2,000,000 of gross proceeds from the Prior Note financing.

 

On April 17, 2023, we entered into an additional Secured Bridge Note (“New Note”) financing with the same accredited investor from the Prior Note financing. We received $750,000 of gross proceeds from the New Note financing. The New Note was issued with a principal amount of $825,000, 10% interest rate and a maturity date on July 31, 2023. The New Note is secured by a lien on substantially all of our assets. At maturity of the New Note, the accredited investor, or our lender, has the option to convert any original issue discount and accrued but unpaid interest into shares of our common stock at a fixed conversion price of $15.25 per share.

 

In connection with the New Note financing, we issued 26,000 common stock warrants to the accredited investor with a five-year term and a fixed $15.25 per share exercise price, from which 13,000 of these common stock warrants are exercisable immediately. The remaining 13,000 common stock warrants would only become exercisable if the maturity date of the New Note is extended in accordance with the terms of the New Note. As of July 31, 2023, we extended the maturity date of the New Note to November 30, 2023. Upon the July 31, 2023 extension, the interest rate on the New Note increased to 20% from 10%, and the remaining portion of the 13,000 common stock warrants became exercisable. As of November 30, 2023, we extended the maturity date of the Prior Note and New Note to March 31, 2024. All terms of the Prior Note and New Note, such as interest rate and exercisable common stock warrants remained the same. The accredited investor did not exercise the common stock warrants as of December 31, 2023 or subsequent to December 31, 2023 and as of the date of this filing.

 

Further, in connection with the New Note financing, the parties agreed to make certain amendments to the Prior Note financing. Specifically, the parties agreed to cancel the 12,000 common stock warrants issued as part of the prior financing and, in lieu of the cancelled warrants, issued the investor common stock warrants for 24,000 common shares with an exercise price of $15.25 per common share and a five-year term. From the newly issued 24,000 common stock warrants, 12,000 common stock warrants were exercisable immediately, while the other 12,000 common stock warrants became exercisable at the time of extension of the maturity date of the Prior Note during May of 2023.

 

In order for the accredited investor to receive common shares from a conversion or exercise of the common stock warrants, an approval is required from the shareholders, if the number of common shares to be issued to the accredited investor, when aggregated with all other shares of common stock beneficially or deemed beneficially owned by the accredited investor would (i) result in the investor owning more than the Beneficial Ownership Limitation (as defined below), as determined in accordance with Section 13 of the Securities Exchange Act of 1934 or (ii) otherwise constitute a Change of Control within the meaning of Nasdaq Rule 5635(b). The “Beneficial Ownership Limitation” shall be 19.99% of the number of shares of the common stock outstanding immediately prior to the proposed issuance of shares of common stock.

 

On April 9, 2024, we entered into an Amendment and Waiver Agreement with the Investor relating to the Bridge Notes.

  

We agreed to pay $2.75 million in cash to the Investor in repayment of the principal of the Bridge Notes (exclusive of the $275,000 of original issue discount on the Bridge Notes) shortly after the closing of one or more equity financings with total gross proceeds to us of not less than $6,000,000.

 

On April 26, 2024, we repaid $2.75 million of principal on our Secured Bridge Notes.

 

Effective April 9, 2024, the Investor converted $911,384, which is equal to the (i) unpaid accrued interest on the Bridge Notes plus (ii) the OID on the Bridge Notes, into equity securities.

 

 

 

 

The Rollover Securities consist of (i) 463,337 Prefunded Warrants with a per share exercise price of $0.001 per share and (ii) 463,337 Non-Prefunded Warrants with a per share exercise price equal to $1.967. As of the date and time of the Amendment and Waiver Agreement, the Nasdaq Minimum Price (as defined in the applicable Nasdaq listing rules) for our common stock was $1.966.

 

The number of Prefunded Warrants was determined by dividing the Rollover Amount by $1.967. The number of Non-Prefunded Warrants is equal to the number of Prefunded Warrants (i.e. 100% warrant coverage). The Non-Prefunded Warrants have a price adjustment provision which will adjust the exercise price downward in the event that we issue equity securities in the future at an effective per share price below the then current exercise price. In order to assure compliance with applicable Nasdaq rules, the Non-Prefunded Warrants shall not be exercisable for six months following the date of issue.

 

We issued to the Investor 50,000 Fee Warrants with a five-year term as a loan extension fee. The exercise price of these additional Fee Warrants is $1.967. The Fee Warrants have a price adjustment provision which will adjust the exercise price downward in the event that we issue equity securities in the future at an effective per share price below the then current exercise price. In order to assure compliance with applicable Nasdaq rules, the Fee Warrants shall not be exercisable for six months following the date of issue.

 

We agreed to adjust the exercise price of the Investor’s Existing Warrants from $15.25 (after adjustment for the recent reverse stock) to $1.967 per share. 

  

The Investor will not be able to receive shares upon exercise of any of the foregoing securities, unless prior stockholder approval is obtained, if (i) the number of shares to be issued would exceed 20% of our outstanding number of shares at a discount to the applicable Nasdaq Minimum Price or (ii) the number of shares to be issued would result in in a Change of Control within the meaning of Nasdaq Rule 5635(b).

 

Equity Line Sales of Common Stock

 

On November 14, 2022, we entered into a Common Stock Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC, a Nevada limited liability company (“White Lion”) for an equity line facility.

 

On April 17 and April 20, 2023, we closed on two sales of Common Stock under the White Lion Purchase Agreement. We issued an aggregate of 1,962,220 common shares and received aggregate proceeds of approximately $1.12 million.

 

Replacement Equity Line with White Lion

 

On November 6, 2023, we entered into a new Common Stock Purchase Agreement and a related registration rights agreement with White Lion. Pursuant to the new Common Stock Purchase Agreement, we have the right, but not the obligation to require White Lion to purchase, from time to time until December 31, 2024, up to $10,000,000 in aggregate gross purchase price of newly issued shares of our common stock, subject to certain limitations and conditions set forth in the Common Stock Purchase Agreement. In connection with the new Common Stock Purchase Agreement, the parties agreed to terminate the previous Common Stock Purchase Agreement with White Lion.

 

Through September 30, 2024, we have sold 4,815,263 shares to White Lion for total proceeds of $8,176,048. We currently have effective registration statements that registers for resale by White Lion up to 2,200,090 remaining shares of common stock that we may issue to White Lion under the Equity Line Purchase Agreement. After White Lion has acquired shares under the Equity Line Purchase Agreement, it may sell all, some or none of those shares. Sales to White Lion by us pursuant to the Equity Line Purchase Agreement may result in substantial dilution to the interests of other holders of our common stock.

 

 

 

 

Cash Flow Analysis

 

Our cash flows from operating activities have historically been significantly impacted by our investment in sales and marketing to drive growth, and research and development expenses. Our ability to meet future liquidity needs will be driven by our operating performance and the extent of continued investment in our operations. Failure to generate sufficient revenues and related cash flows could have a material adverse effect on our ability to meet our liquidity needs and achieve our business objectives.

 

The following table summarizes the statements of cash flows for the nine months ended September 30, 2024 and 2023:

 

		Nine Months Ended September 30,
		2024				2023
Net cash provided by (used in):
Operating activities		$	(3,803,324	)		$	(3,404,954	)
Investing activities			(799,535	)			(743,208	)
Financing activities			7,572,130				4,686,406
Change in cash		$	2,969,271			$	538,244

 

Operating activities

 

Cash used in operating activities for the nine months ended September 30, 2024 was ($3,803,324), primarily resulting from our net loss of ($6,460,181) and change in working capital of $112,262, offset by non-cash charges of $2,544,594 related to depreciation and amortization, share based compensation expense, and the change in fair value of warrants. Cash used in operating activities for both periods consisted of personnel-related expenditures, marketing and promotion costs, and public company administrative support costs such as legal and other professional support services.

 

Cash used in operating activities for the nine months ended September 30, 2023, was ($3,404,954), primarily resulting from our net loss of ($6,594,656) and change in working capital of $188,517 related to an increase in accounts payable and accrued liabilities, offset by non-cash charges of $3,001,184 related to depreciation and amortization, share based compensation expense, and finance charges associated with the debt issuance costs of the Secured Bridge Notes. Cash used in operating activities for both periods consisted of personnel-related expenditures, marketing and promotion costs, and public company administrative support costs such as legal and other professional support services.

 

Investing activities

 

Cash used in investing activities for the nine months ended September 30, 2024 was ($799,535), consisting of the capitalization of software development expenses and purchase of computer equipment.

 

Cash used in investing activities for the nine months ended September 30, 2023 was ($743,208), consisting entirely of capitalization of software development expenses.

 

Financing activities

 

Cash provided by financing activities for the nine months ended September 30, 2024 was $7,572,130, which consisted of cash proceeds from the issuance of common shares of $8,176,048 and cash proceeds from the issuance of preferred shares of $2,238,575. This was partially offset by the repayment of the note payable to related party of $2,750,000, payment of offering costs of $72,807 and net settlement of share-based compensation liability of $19,686.

 

 

 

 

Cash provided by financing activities for the nine months ended September 30, 2023 was $4,686,406 and related primarily to cash proceeds from the issuance of common shares of $4,016,521 and proceeds from related party debt of $750,000.

 

Funding Requirements

 

We historically have incurred significant losses and negative cash flows from operations since our inception and had an accumulated deficit of $87,003,511 and $80,543,330 as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 and December 31, 2023, we had cash and cash equivalents of $3,773,827 and $804,556, respectively. Our cash is comprised primarily of demand deposit accounts and money market funds. We secured $10.4 million of additional financing in 2024, which enabled us to pay down $2.75 million in connection with the Secured Bridge Notes and will only be sufficient to fund our current operating plans into the first quarter of 2025. We have based these estimates, however, on assumptions that may prove to be wrong. We will need additional funding to complete the development of our full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. If we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

 

We expect our expenses to increase in connection with our ongoing activities, particularly as we continue the development, and marketing and promotion of faidr. In addition, we expect to continue to incur additional costs associated with operating as a public company, including legal, accounting, investor relations and other expenses. Our future funding requirements will depend on many factors, including, but not limited to:

 

	·	the scope, progress, results, and costs related to the market acceptance of our products;
	·	the ability to attract podcasters and content creators to faidr and retain listeners on the platform;
	·	the costs, timing, and ability to continue to develop our technology;
	·	effectively addressing any competing technological and market developments; and
	·	avoiding and defending against intellectual property infringement, misappropriation and other claims.

 

Contractual Obligations

 

The following table summarizes our contractual obligations as of September 30, 2024, and the effects that such obligations are expected to have on our liquidity and cash flows in future periods:

 

		Payments due by period
		Total				Less Than 1 Year				1 - 3 Years				4 - 5 Years				More Than 5 Years
Operating lease commitments:
Office lease (1)		$	98,233			$	32,540			$	65,693			$	–			$	–
Total operating lease commitments		$	98,233			$	32,540			$	65,693			$	–			$	–

 

(1)	Represents minimum payments due for the lease of office space.

 

Off-balance sheet arrangements

 

We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.

 

 

 

 

Critical Accounting Estimates

 

Our financial statements and accompanying notes have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses, and related disclosures. On an ongoing basis, we continually evaluate our estimates and assumptions believed to be reasonable under current facts and circumstances. Actual amounts and results may materially differ from these estimates made by management under different assumptions and conditions.

 

Certain accounting policies that require significant management estimates and are deemed critical to our results of operations or financial position, are described below. Accordingly, these are the policies we believe are the most critical to aid in fully understanding and evaluating our financial condition and results of operations.

 

Software Development Costs

 

The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable. The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies. Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are impaired and expensed during the period of such determination.

 

Equity-based compensation

 

Certain of our employees and consultants have received grants of common shares in our company. These awards are accounted for in accordance with guidance prescribed for accounting for equity-based compensation. Based on this guidance and the terms of the awards, the awards are equity classified. The common shares receive distributions if any in an order of priority in accordance with our limited liability company agreement.

 

The fair value of each award is determined using the Black-Scholes option-pricing model which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, and the risk-free interest rate over the expected life of the option. The expected volatility was determined considering comparable companies historical stock prices as a peer group for the fiscal year the grant occurred and prior fiscal years for a period equal to the expected life of the option. The risk-free interest rate was the rate available from the St. Louis Federal Reserve Bank with a term equal to the expected life of the option. The expected life of the option was estimated based on a mid-point method calculation.

 

Prior to our IPO in February 2021, we were a private company with no active public market for our common equity. Therefore, we have periodically determined the overall value of our company and the estimated per share fair value of our common equity at their various dates using contemporaneous valuations performed with the assistance of a third-party specialist and in accordance with the guidance outlined in the American Institute of CPA’s Practice Aid.

 

Emerging growth company and smaller reporting company status

 

The Jumpstart Our Business Startups Act of 2012 permits an “emerging growth company” such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to not “opt out” of this provision and, as a result, we will adopt new or revised accounting standards at the time private companies adopt the new or revised accounting standard and will do so until such time that we either (i) irrevocably elect to “opt out” of such extended transition period or (ii) no longer qualify as an emerging growth company.

 

 

 

 

We are also a “smaller reporting company” meaning that the market value of our stock held by non-affiliates is less than $700 million and our annual revenue was less than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

Item 4.

Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were effective after taking remedial actions to address the material weaknesses in internal control over financial reporting reported in prior filings. The Company’s disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms; and (ii) accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely discussions regarding required disclosure. We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

 

Changes in Internal Control Over Financial Reporting

 

Management has been actively engaged in remediating the material weaknesses discussed in our Form 10-K for the period ended December 31, 2023 filed with SEC on April 1, 2024. The following remedial actions have been taken during the nine months ended September 30, 2024:

 

	·	Completed the internal control documentation along with engaging outside consultants to assist in the design, implementation and documentation of internal controls to address the relevant risks;
	·	Performed risk-based scoping activities to identify key business processes, and engaged an outside internal control specialist team to assist in designing, documenting, and implementing internal controls to address relevant risks;
	·	Implemented the internal control procedures identified in the scoping and documentation processes;
	·	Hired additional accounting resources with appropriate levels of experience, including a new Chief Financial Officer in 2023; and
	·	Continue to engage outside consultants to ensure that the appropriate level of knowledge and experience is applied based on risk and complexity of transactions and tasks under review.

 

The process of implementing an effective financial reporting system is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments and to expend significant resources to maintain a financial reporting system that is adequate to satisfy our reporting obligations. As we continue to evaluate and take actions to improve our internal control over financial reporting, we may take additional actions to address control deficiencies or modify certain of the remediation measures described above.

 

We believe the above actions will be effective in remediating the material weaknesses described above and we will continue to devote significant time and attention to these remedial efforts.

 

 

 

 

PART II – OTHER INFORMATION

 

Item 1.

Legal Proceedings

 

From time to time, we are involved in various disputes, claims, suits, investigations, and legal proceedings arising in the ordinary course of business. We believe that the resolution of current pending legal matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows. Nonetheless, we cannot predict the outcome of these proceedings, as legal matters are subject to inherent uncertainties, and there exists the possibility that the ultimate resolution of these matters could have a material adverse effect on our business, financial condition, results of operations or cash flows. For additional information, see “Note 5. Commitments and Contingencies” to our financial statements included in this Form 10-Q.

 

Item 1A.

Risk Factors

 

In addition to the information set forth in this Form 10-Q, you should carefully consider the risk factors disclosed under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023. There have been no material changes to our risk factors from those included in our Annual Report on Form 10-K for the year ended December 31, 2023.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

Not applicable.

 

Issuer Purchases of Equity Securities

 

We did not repurchase any of our equity securities during the quarter ended September 30, 2024.

 

Item 3.

Defaults Upon Senior Securities

 

None.

 

Item 4.

Mine Safety Disclosures

 

None.

 

Item 5.

Other Information

 

During the quarter ended September 30, 2024, no director or officer of the Company adopted or terminated or otherwise had in effect a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

 

 

 

Item 6.

Exhibits

 

The exhibits required by Item 601 of Regulation S-K and Item 15(b) of this Quarterly Report are listed in the Exhibit Index below. The exhibits listed in the Exhibit Index are incorporated by reference herein.

 

Exhibit Number		Description of Document		Incorporated by reference from Form		Filing Date		Exhibit Number		Filed Herewith
1.1		At-The-Market Issuance Sales Agreement, dated September 13, 2024, by and between Auddia Inc. and Ascendiant Capital Markets, LLC.		8-K		09-13-2024		1.1
2.2		Form of Plan of Conversion		8-K		02-22-2021		2.1
3.1		Certificate of Incorporation of the Company		8-K		02-22-2021		3.1
3.2		Certificate of Designation of Series A Preferred Stock filed November 13, 2023		8-K		11-16-2023		3.1
3.3		Certificate of Amendment to the Certificate of Incorporation of the Company dated February 23, 2024		8-K		02-27-2024		3.1
3.4		Series B Convertible Preferred Stock Certificate of Designations dated April 23, 2024		8-K		04-29-2024		3.1
3.5		Bylaws of the Company		8-K		02-22-2021		3.2
3.6		Amendment to Bylaws dated September 6, 2024		8-K		9-12-2024		3.1
3.7		Form of Warrant after Conversion from an LLC to a Corporation		S-1/A		01-28-2020		3.5
3.8		Form of IPO Series A Warrant		S-1/A		02-05-2021		3.6
4.1		Form of Common Stock Certificate		S-1/A		10-08-2020		4.1
4.2		Form of IPO Representative’s Common Stock Purchase Warrant		8-K		02-22-2021		4.1
4.3		Description of Securities		10-K		03-31-2021		4.3
10.1	#	Employment Agreement of Michael T. Lawless		S-1		01-10-2020		10.1
10.2	#	Employment Agreement of Peter Shoebridge		S-1		01-10-2020		10.2
10.3	#	Form of Auddia Inc. 2020 Equity Incentive Plan		S-1/A		10-22-2020		10.3
10.4		Collateral and Security Agreement with Related Party (Minicozzi)		S-1/A		01-28-2020		10.4
10.5		Form of Amendment to Collateral and Security Agreement with Related Party		S-1/A		10-08-2020		10.5
10.6		Form of Convertible Promissory Note		S-1/A		01-28-2020		10.6
10.7		Business Loan Agreement and Guaranty of Related Party with Bank of the West		S-1/A		01-28-2020		10.7
10.8	**	Agreement with Major United States Broadcast Company		S-1/A		01-28-2020		10.8
10.9		Form of Bridge Note		S-1/A		10-22-2020		10.9
10.10		Form of IPO Series A Warrant Agent Agreement		S-1/A		02-05-2021		10.10
10.11		Amendment to Bridge Note		S-1/A		10-22-2020		10.14
10.12		Amended Business Loan Agreement with Bank of the West		10-K		03-31-2021		10.15
10.13	#	First Amendment to 2020 Equity Incentive Plan		S-8		08-10-2021		99.2
10.14	#	Form of Stock Option Grant Notice and Stock Option Agreement under 2020 Equity Incentive Plan		S-8		08-10-2021		99.3
10.15	#	Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under 2020 Equity Incentive Plan		S-8		08-10-2021		99.4
10.16	#	Form of Inducement Stock Option Grant Notice and Inducement Stock Option Agreement		S-8		08-10-2021		99.5
10.17	#	Clip Interactive, LLC 2013 Equity Incentive Plan		S-8		08-10-2021		99.6
10.18	#	Form of Stock Option Grant Notice and Stock Option Agreement under 2013 Equity Incentive Plan		S-8		08-10-2021		99.7
10.19	#	Executive Officer Employment Agreement for Michael Lawless dated October 13, 2021		8-K		10-15-2021		10.1
10.20	#	Executive Officer Employment Agreement for Peter Shoebridge dated October 13, 2021		8-K		10-15-2021		10.2

 

 

 

 

Exhibit Number		Description of Document		Incorporated by reference from Form		Filing Date		Exhibit Number		Filed Herewith
10.21	#	Executive Officer Employment Agreement for Brian Hoff dated October 13, 2021		8-K		10-15-2021		10.3
10.22	#	Executive Officer Employment Agreement for Timothy Ackerman effective as of February 6, 2023		8-K		02-16-2023		10.1
10.23		Secured Promissory Bridge Note dated November 14, 2022		8-K		11-14-2022		10.1
10.24		Common Stock Warrant dated November 14, 2022		8-K		11-14-2022		10.2
10.25		Security Agreement dated November 14, 2022		8-K		11-14-2022		10.3
10.26		Common Stock Purchase Agreement, dated November 14, 2022, by and between Auddia Inc. and White Lion Capital LLC		8-K		11-14-2022		10.4
10.27		Secured Promissory Bridge Note dated November 14, 2022		8-K		11-14-2022		10.1
10.28		Common Stock Warrant dated November 14, 2022		8-K		11-14-2022		10.2
10.29		Security Agreement dated November 14, 2022		8-K		11-14-2022		10.3
10.30		Common Stock Purchase Agreement, dated November 14, 2022, by and between Auddia Inc. and White Lion Capital LLC		8-K		11-14-2022		10.4
10.31		Secured Promissory Bridge Note dated April 17, 2023		8-K		04-21-2023		10.1
10.32		Common Stock Warrant for 600,000 shares dated April 17, 2023		8-K		04-21-2023		10.2
10.33		Common Stock Warrant for 650,000 shares dated April 17, 2023		8-K		04-21-2023		10.3
10.34		Form of 2023 Placement Agency Agreement		8-K		06-14-23		1.1
10.35		Form of Securities Purchase Agreement dated June 13, 2023 between Auddia Inc. and the Investors named therein		8-K		06-14-23		10.1
10.36		Common Stock Purchase Agreement, dated as of November 6, 2023, by and between White Lion Capital, LLC and Auddia Inc.		8-K		11-06-23		10.1
10.37		Registration Rights Agreement, dated as of November 6, 2023, by and between White Lion Capital, LLC and Auddia Inc.		8-K		11-06-23		10.2
10.38	#	Employment Agreement, effective as of November 27, 2023, between Auddia Inc. and John E. Mahoney		8-K		12-18-2023		10.1
10.39		Series A Preferred Securities Purchase Agreement dated November 11, 2023 between Auddia Inc. and Jeffrey Thramann		8-K		11-16-2023		10.1
10.40		Amendment and Waiver dated April 9, 2024 Relating to Senior Secured Bridge Notes		8-K		04-15-2024		10.1
10.41		Form of Securities Purchase Agreement dated April 23, 2024		10-Q		05-14-2024		10.41
10.42		Form of Common Stock Warrant dated April 23, 2024		8-K		04-29-2024		10.2
10.43		Form of Registration Rights Agreement dated April 23, 2024		8-K		04-29-2024		10.3
31.1		Section 302 Certification by the Corporation’s Chief Executive Officer								X
31.2		Section 302 Certification by the Corporation’s Chief Financial Officer								X
32.1		Section 906 Certification by the Corporation’s Chief Executive Officer								X
32.2		Section 906 Certification by the Corporation’s Chief Financial Officer								X
97.1		Auddia Clawback Policy		10-K		04-01-2024		97.1

101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted in IXBRL, and included in exhibit 101).

___________________________

#	Indicates management contract or compensatory plan.
**	Certain information contained in this Exhibit has been redacted and appears as “XXXXX” as the disclosure of same would be a disadvantage to the Registrant in the marketplace

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	AUDDIA INC.
	By:	/s/ Michael Lawless
		Michael Lawless President, Chief Executive Officer, Director

 

	By:	/s/ John Mahoney
		John Mahoney Chief Financial Officer

 

 

Date:  November 7, 2024

 

 

 

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO RULES 13a-14(a) OR 15D-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Michael Lawless, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2024, of Auddia Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

 

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

November 7, 2024

 

/s/ Michael Lawless                            

Michael Lawless

Chief Executive Officer

(Principal Executive Officer)

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULES 13a-14(a) OR 15D-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, John Mahoney, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2024, of Auddia Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

 

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

November 7, 2024

 

/s/ John Mahoney                            

John Mahoney

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Auddia Inc. (the “Company”) on Form 10-Q, for the period ended September 30, 2024, as filed with the Securities and Exchange Commission, I, Michael Lawless, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Quarterly Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

November 7, 2024

 

/s/   Michael Lawless                            

Michael Lawless

Chief Executive Officer

(Principal Executive Officer)

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Auddia Inc. (the “Company”) on Form 10-Q, for the period ended September 30, 2024, as filed with the Securities and Exchange Commission, I, John Mahoney, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Quarterly Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

November 7, 2024

 

/s/   John Mahoney                            

John Mahoney

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

v3.24.3

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 07, 2024
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-40071
Entity Registrant Name	AUDDIA INC.
Entity Central Index Key	0001554818
Entity Tax Identification Number	45-4257218
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1680 38th Street
Entity Address, Address Line Two	Suite 130
Entity Address, City or Town	Boulder
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80301
City Area Code	303
Local Phone Number	219-9771
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		5,673,675
Common Stock, par value $0.001 per share [Member]
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	AUUD
Security Exchange Name	NASDAQ
Warrants, each exercisable for one share of Common Stock [Member]
Title of 12(b) Security	Warrants, each exercisable for one share of Common Stock
Trading Symbol	AUUDW
Security Exchange Name	NASDAQ

v3.24.3

Condensed Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 3,773,827	$ 804,556
Accounts receivable, net	292	494
Prepaid assets	63,823	50,608
Other current assets	10,039	7,150
Total current assets	3,847,981	862,808
Non-current assets:
Property and equipment, net of accumulated depreciation	14,228	18,099
Intangible assets, net of accumulated amortization	3,482	3,947
Software development costs, net of accumulated amortization	2,678,716	3,347,935
Operating lease right of use asset	81,386	0
Deferred offering costs	65,905	170,259
Total non-current assets	2,843,717	3,540,240
Total assets	6,691,698	4,403,048
Current liabilities:
Accounts payable and accrued liabilities	441,726	911,664
Notes payable to related party, net of debt issuance costs	0	3,025,000
Current portion of operating lease liability	23,374	0
Stock awards liability	26,276	45,964
Total current liabilities	491,376	3,982,628
Non-current operating lease liability	63,654	0
Total liabilities	555,030	3,982,628
Commitments and contingencies (Note 5)
Shareholders' equity:
Series B Preferred stock - $0.001 par value, 2,314 and 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	2	0
Common stock - $0.001 par value, 100,000,000 authorized and 5,673,675 and 854,162 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	5,674	854
Additional paid-in capital	93,237,155	80,962,896
Accumulated deficit	(87,106,163)	(80,543,330)
Total shareholders' equity	6,136,668	420,420
Total liabilities and shareholders' equity	$ 6,691,698	$ 4,403,048

v3.24.3

Condensed Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	5,673,675	854,162
Common stock, shares outstanding	5,673,675	854,162
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	2,314	0
Preferred stock, shares outstanding	2,314	0

v3.24.3

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
Direct cost of services	54,916	43,470	153,316	130,809
Sales and marketing	282,450	316,297	645,713	765,176
Research and development	233,085	227,133	558,180	617,622
General and administrative	881,439	777,496	2,826,563	2,596,831
Depreciation and amortization	495,960	465,166	1,473,088	1,350,820
Total operating expenses	1,947,850	1,829,562	5,656,860	5,461,258
Loss from operations	(1,947,850)	(1,829,562)	(5,656,860)	(5,461,258)
Other expense:
Interest expense	(1,578)	(286,920)	(170,933)	(1,133,398)
Change in fair value of warrants	0	0	(632,388)	0
Total other expense	(1,578)	(286,920)	(803,321)	(1,133,398)
Loss before income taxes	(1,949,428)	(2,116,482)	(6,460,181)	(6,594,656)
Provision for income taxes	0	0	0	0
Net loss	$ (1,949,428)	$ (2,116,482)	$ (6,460,181)	$ (6,594,656)
Net loss per share attributable to common stockholders
Net loss per share attributable to common stockholders, Basic	$ (0.50)	$ (2.65)	$ (2.51)	$ (10.28)
Net loss per share attributable to common stockholders, Diluted	$ (0.50)	$ (2.65)	$ (2.51)	$ (10.28)
Weighted average common shares outstanding
Weighted average common shares outstanding, Basic	3,920,409	797,889	2,570,299	641,723
Weighted average common shares outstanding, Diluted	3,920,409	797,889	2,570,299	641,723

v3.24.3

Condensed Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock Series B [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2022	$ 0	$ 506	$ 75,585,411	$ (71,735,834)	$ 3,850,083
Beginning balance, shares at Dec. 31, 2022	0	506,198
Exercise of restricted stock units and warrants		$ 8	42,789		42,797
Exercise of restricted stock units and warrants, shares		7,830
Share-based compensation			357,680		357,680
Net loss				(2,155,312)	(2,155,312)
Ending balance, value at Mar. 31, 2023	$ 0	$ 514	75,985,880	(73,891,146)	2,095,248
Ending balance, shares at Mar. 31, 2023	0	514,028
Beginning balance, value at Dec. 31, 2022	$ 0	$ 506	75,585,411	(71,735,834)	3,850,083
Beginning balance, shares at Dec. 31, 2022	0	506,198
Net loss					(6,594,656)
Ending balance, value at Sep. 30, 2023	$ 0	$ 798	80,744,705	(78,330,490)	2,415,013
Ending balance, shares at Sep. 30, 2023	0	797,888
Beginning balance, value at Mar. 31, 2023	$ 0	$ 514	75,985,880	(73,891,146)	2,095,248
Beginning balance, shares at Mar. 31, 2023	0	514,028
Issuance of common shares, net of costs		$ 284	3,963,600		3,963,884
Issuance of common shares, net of costs, shares		283,861
Issuance of warrants			383,004		383,004
Share-based compensation			224,856		224,856
Revaluation of share-based compensation liability			(12,352)		(12,352)
Net loss				(2,322,862)	(2,322,862)
Ending balance, value at Jun. 30, 2023	$ 0	$ 798	80,544,988	(76,214,008)	4,331,778
Ending balance, shares at Jun. 30, 2023	0	797,888
Share-based compensation			217,141		217,141
Revaluation of share-based compensation			(17,424)		(17,424)
Net loss				(2,116,482)	(2,116,482)
Ending balance, value at Sep. 30, 2023	$ 0	$ 798	80,744,705	(78,330,490)	2,415,013
Ending balance, shares at Sep. 30, 2023	0	797,888
Beginning balance, value at Dec. 31, 2023	$ 0	$ 854	80,962,896	(80,543,330)	420,420
Beginning balance, shares at Dec. 31, 2023	0	854,162
Issuance of common shares, net of costs		$ 1,340	3,605,168		3,606,508
Issuance of common shares, net of costs, shares		1,340,034
Offering costs			(44,404)		(44,404)
Share-based compensation			173,289		173,289
Net loss				(2,207,328)	(2,207,328)
Ending balance, value at Mar. 31, 2024	$ 0	$ 2,194	84,696,949	(82,750,658)	1,948,485
Ending balance, shares at Mar. 31, 2024	0	2,194,196
Beginning balance, value at Dec. 31, 2023	$ 0	$ 854	80,962,896	(80,543,330)	420,420
Beginning balance, shares at Dec. 31, 2023	0	854,162
Net loss					(6,460,181)
Ending balance, value at Sep. 30, 2024	$ 2	$ 5,674	93,237,155	(87,106,163)	6,136,668
Ending balance, shares at Sep. 30, 2024	2,314	5,673,675
Beginning balance, value at Mar. 31, 2024	$ 0	$ 2,194	84,696,949	(82,750,658)	1,948,485
Beginning balance, shares at Mar. 31, 2024	0	2,194,196
Issuance of common shares, net of costs		$ 600	1,245,400		1,246,000
Issuance of common shares, net of costs, shares		600,000
Issuance of Series B preferred stock and warrants	$ 2		2,238,573		2,238,575
Issuance of Series B preferred stock and warrants, shares	2,314
Conversion of debt to equity			1,543,772		1,543,772
Offering costs			(97,333)		(97,333)
Share-based compensation			132,488		132,488
Net loss				(2,303,425)	(2,303,425)
Ending balance, value at Jun. 30, 2024	$ 2	$ 2,794	89,759,849	(85,054,083)	4,708,562
Ending balance, shares at Jun. 30, 2024	2,314	2,794,196
Issuance of common shares, net of costs		$ 2,876	3,320,665		3,323,541
Issuance of common shares, net of costs, shares		2,875,263
Issuance of restricted stock units		$ 4	(4)
Issuance of restricted stock units, shares		4,216
Capitalized dividends			102,652	(102,652)
Offering costs			(65,423)		(65,423)
Share-based compensation			119,416		119,416
Net loss				(1,949,428)	(1,949,428)
Ending balance, value at Sep. 30, 2024	$ 2	$ 5,674	$ 93,237,155	$ (87,106,163)	$ 6,136,668
Ending balance, shares at Sep. 30, 2024	2,314	5,673,675

v3.24.3

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net loss	$ (6,460,181)	$ (6,594,656)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Finance charge associated with debt issuance cost	0	850,688
Depreciation and amortization	1,473,089	1,350,820
Share-based compensation expense	425,193	799,677
Change in fair value of warrants	632,388	(0)
Amortization of ROU asset	13,925	0
Change in assets and liabilities:
Accounts receivable	203	(437)
Prepaid assets	(13,215)	(56,705)
Other current assets	(2,889)	4,390
Accounts payable and accrued liabilities	136,447	241,269
Lease liabilities	(8,284)	0
Net cash used in operating activities	(3,803,324)	(3,404,954)
Cash flows from investing activities:
Purchase of property and equipment	(12,199)	0
Software capitalization	(787,336)	(743,208)
Net cash used in investing activities	(799,535)	(743,208)
Cash flows from financing activities:
Offering costs in connection with the issuance of preferred shares	(72,807)	0
Net settlement of share-based compensation liability	(19,686)	(80,115)
Proceeds from related party debt, net of original issue discount	0	750,000
Repayments of related party debt	(2,750,000)	0
Proceeds from issuance of preferred shares, net of issuance costs	2,238,575	0
Proceeds from issuance of common shares, net of issuance costs	8,176,048	4,016,521
Net cash provided by financing activities	7,572,130	4,686,406
Net decrease in cash	2,969,271	538,244
Cash, beginning of year	804,556	1,661,434
Cash and restricted cash, end of period	3,773,827	2,199,678
Supplemental disclosures of cash flow information:
Cash paid for interest	1,045	6,000
Cash paid for taxes	0	0
Supplemental disclosures of non-cash activity:
Reclassification of deferred offering costs	134,354	52,637
Capitalized dividends	102,652	0
Original issue discount and issuance of warrants on related party debt	0	458,004
Issuance of warrants in connection with related party notes	911,384	0
Right of use asset and assumption of operating lease liability	$ 95,311	$ 0

v3.24.3

Pay vs Performance Disclosure - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ (1,949,428)	$ (2,303,425)	$ (2,207,328)	$ (2,116,482)	$ (2,322,862)	$ (2,155,312)	$ (6,460,181)	$ (6,594,656)

v3.24.3

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

v3.24.3

Description of Business, Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Description of Business, Basis of Presentation and Summary of Significant Accounting Policies	Note 1 – Description of Business, Basis of Presentation and Summary of Significant Accounting Policies   Description of Business   Auddia Inc., (the “Company”, “Auddia”, “we”, “our”) is a technology company that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company is incorporated in Delaware and headquartered in Colorado.   Basis of Presentation   The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”).   Interim Financial Information   The condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. The condensed balance sheet as of December 31, 2023 has been derived from the financial statements included in the Company’s annual report on Form 10-K. Accordingly, these condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K. The results for any interim period are not necessarily indicative of results for any future period. The Company recorded all adjustments necessary for a fair statement of the results for the interim period and all such adjustments are of a normal recurring nature.   Reverse Stock Split   The Company filed an amendment to its Certificate of Incorporation with the Secretary of State in Delaware which became effective as of 5:00 P.M. Eastern Time on February 26, 2024. As a result, every twenty-five (25) issued shares of common stock were automatically combined into one share of common stock.   Shares of the Company’s common stock were assigned a new CUSIP number (05072K 206) and began trading on a split-adjusted basis on February 27, 2024.   The reverse stock split did not change the authorized number of shares of the Company’s common stock. No fractional shares were issued and any fractional shares resulting from the reverse stock split were rounded up to the nearest whole share. Therefore, stockholders with less than 25 shares received one share of stock.   All stock amounts have been retrospectively adjusted to account for the reverse stock split. The reverse stock split applies to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable were adjusted proportionately as a result of the reverse stock split. The exercise prices of any outstanding warrants or stock options were also proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans.   Use of Estimates   The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.   The condensed financial statements include some amounts that are based on management’s best estimates and judgments. The most significant estimates relate to valuation of capital stock, warrants and options to purchase shares of the Company’s common stock, and the estimated recoverability and amortization period for capitalized software development costs. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.   Risks and Uncertainties   The Company is subject to various risks and uncertainties frequently encountered by companies in the early stages of development. Such risks and uncertainties include, but are not limited to, its limited operating history, competition from other companies, limited access to additional funds, dependence on key personnel, and management of potential rapid growth. To address these risks, the Company must, among other things, develop its customer base; implement and successfully execute its business and marketing strategy; develop follow-on products; provide superior customer service; and attract, retain, and motivate qualified personnel. There can be no guarantee that the Company will be successful in addressing these or other such risks.   Emerging Growth Company Status   The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period to comply with certain new or revised accounting standards that have different effective dates for public and private companies.   Going Concern   The Company had cash and cash equivalents of $3,773,827 as of September 30, 2024. The Company will need additional funding to complete the development of the full product line and scale products with a demonstrated market fit. The Company raised an additional $10.4 million during 2024 and paid down $2.75 million in Secured Bridge Notes and will only be sufficient to fund our current operating plans into the first quarter of 2025. Management has plans to secure such additional funding. If the Company is unable to raise capital when needed or on acceptable terms, the Company will be forced to delay, reduce, or eliminate technology development and commercialization efforts.   As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. Management has plans to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern, such as the White Lion equity line of credit (refer to Note 7) and additional future financing agreements. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s current level of cash is not sufficient to execute the business plan. For the foreseeable future, the Company will incur significant operating expenses, capital expenditures and working capital funding that will deplete cash on hand during the first quarter of 2025.   Cash and Cash Equivalents   The Company had cash on hand of $3,770,855 and $801,448 as of September 30, 2024 and December 31, 2023, respectively.   The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company had cash equivalents of $2,972 and $3,108 as of September 30, 2024 and December 31, 2023, respectively.   The Company maintains cash deposits at several financial institutions, which are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. As of September 30, 2024, the Company had approximately $3.5 million in excess of federally insured limits. As of December 31, 2023, the Company had approximately $0.6 million in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests.   Software Development Costs   The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable.   The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies.   Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are considered impaired and expensed during the period of such determination. The Company determined that no such impairments were required during the three and nine months ended September 30, 2024 and 2023. Software development costs of $258,734 and $213,705 were capitalized for the three months ended September 30, 2024 and 2023, respectively. Software development costs of $787,336 and $743,208 were capitalized for the nine months ended September 30, 2024 and 2023, respectively. Amortization of capitalized software development costs was $492,872 and $458,973 for the three months ended September 30, 2024, and 2023, respectively and $1,456,554 and $1,331,823 for the nine months ended September 30, 2024 and 2023, respectively, and is included in depreciation and amortization expense in the Company’s condensed statement of operations.   Revenue Recognition   Revenue will be measured according to Accounting Standards Codification (“ASC”) 606, Revenue – Revenue from Contracts with Customers, and will be recognized based on consideration specified in a contract with a customer, and excludes any sales incentives and amounts collected on behalf of third parties. The Company will recognize revenue when a performance obligation is satisfied by transferring control over a service or product to a customer. The Company will report revenues net of any tax assessed by a governmental authority that is both imposed on, and concurrent with, a specific revenue-producing transaction between a seller and a customer in the condensed statements of operations. Collected taxes will be recorded within Other current liabilities until remitted to the relevant taxing authority.   Subscriber revenue will consist primarily of subscription fees and other ancillary subscription-based revenues. Revenue will be recognized on a straight-line basis when the performance obligations to provide each service for the period are satisfied, which is over time as our subscription services are continuously available and can be consumed by customers at any time. There is no revenue recognized for unpaid trial subscriptions.   Customers may pay for the services in advance of the performance obligation and therefore these prepayments would be recorded as deferred revenue. The deferred revenue will be recognized as revenue in the statement of operations as the services are provided.   Share-Based Compensation   The Company accounts for share-based compensation arrangements with employees, directors, and consultants and recognizes the compensation expense for share-based awards based on the estimated fair value of the awards on the date of grant in accordance with ASC 718.   Compensation expense for all share-based awards is based on the estimated grant-date fair value and recognized in earnings over the requisite service period (generally the vesting period). The Company records share-based compensation expense related to non-employees over the related service periods.   Certain share-based compensation awards include a net-share settlement feature that provides the grantee an option to withhold shares to satisfy tax withholding requirements and are classified as a share-based compensation liability. Cash paid to satisfy tax withholdings is classified as financing activities in the condensed statements of cash flows.   Warrants   The Company account for warrants as equity-classified instruments, based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.   In connection with the amendment to the Secured Bridge Notes (see Note 4), the Company converted $911,384, consisting of accrued interest and the original issue discount on the Bridge Notes, into equity securities. As a result of the conversion, the Company recognized a change in the fair value of warrants in the amount of $0 and $632,388 during the three and nine months ended September 30, 2024.   Reclassifications   Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not have an impact on net loss as previously reported.

v3.24.3

Property & Equipment, Intangible Assets, and Software Development Costs	9 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Property & Equipment, Intangible Assets, and Software Development Costs	Note 2 – Property & Equipment, Intangible Assets, and Software Development Costs   Property and equipment and software development costs consisted of the following as of:  Schedule of property and equipment and software development costs                 September 30, 2024     December 31, 2023                 Computers and equipment   $ 110,551     $ 102,348   Furniture     11,258       7,263   Accumulated depreciation     (107,581 )     (91,512 ) Total property and equipment, net   $ 14,228     $ 18,099                     Domain name   $ 3,947     $ 3,947   Accumulated amortization     (465 )     –   Total intangible assets, net   $ 3,482     $ 3,947                     Software development costs   $ 8,442,542     $ 7,655,206   Accumulated amortization     (5,763,826 )     (4,307,271 ) Total software development costs, net   $ 2,678,716     $ 3,347,935     The Company recognized depreciation expense of $3,291 and $6,193 for the three months ended September 30, 2024 and 2023, respectively related to property and equipment, amortization expense of $202 and $0 for the three months ended September 30, 2024 and 2023, respectively related to intangible assets, and amortization expense of $492,872 and $458,973 for the three months ended September 30, 2024 and 2023, respectively related to software development costs. The Company recognized depreciation expense of $16,069 and $18,997 for the nine months ended September 30, 2024 and 2023, respectively related to property and equipment, amortization expense of $465 and $0 for the nine months ended September 30, 2024 and 2023, respectively related to intangible assets, and amortization expense of $1,456,554 and $1,331,823 for the nine months ended September 30, 2024 and 2023, respectively related to software development costs.

v3.24.3

Accounts Payable and Accrued Liabilities	9 Months Ended
	Sep. 30, 2024
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities	Note 3 – Accounts Payable and Accrued Liabilities   Accounts payable and accrued liabilities consist of the following:  Schedule of accounts payable and accrued liabilities                 September 30, 2024     December 31, 2023                 Accounts payable and accrued liabilities   $ 434,986     $ 424,510   Credit cards payable     6,740       16,975   Accrued interest     –       470,179   Total accounts payable and accrued liabilities   $ 441,726     $ 911,664

v3.24.3

Notes Payable to Related Party, net of debt issuance costs	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
Notes Payable to Related Party, net of debt issuance costs	Note 4 – Notes Payable to Related Party, net of debt issuance costs   During November 2022, the Company entered into a Secured Bridge Note (the “Prior Note”) financing with an accredited investor and existing shareholder of the Company. The Prior Note had a principal amount of $2,200,000, including an original issue discount of $200,000. The Prior Note bore interest at an annual stated interest rate of 10% with an original maturity date of May of 2023. The Prior Note is secured by a lien on substantially all of the Company’s assets. At maturity, the lender had the option to convert the original issue discount and accrued but unpaid interest into shares of the Company’s common stock at a fixed conversion price of $30.75 per share. The conversion option was available to the lender at the earlier of (i) maturity, or (ii) payback of all the principal. The embedded conversion option was not accounted for separately, in accordance with the guidance outlined in ASC 815-40, as it was considered indexed to the Company’s shares. The Company had the option to extend the maturity date by six months to November 2023. In the event of an extension, the Company will issue additional warrants, and the interest rate on the Note will increase to 20%.   In connection with the Prior Note financing, the Company issued 12,000 common stock warrants with a five-year term at an exercise price of $52.50 per share. At the time of issuance, the common stock warrants were valued at $361,878 and recorded as a debt discount to the Prior Note. The issued common stock warrants were classified as equity as they were indexed to the Company’s shares in accordance with ASC 815-40.   During April 2023, the Company entered into an additional Secured Bridge Note (the “New Note”) financing with the same accredited investor and significant existing shareholder. The New Note had a principal amount of $825,000, including an original issue discount of $75,000. The New Note bore interest at an annual stated interest rate of 10% with an original maturity date of July 2023. The New Note is secured by a lien on substantially all of the Company’s assets. At maturity, the lender had the option to convert the original issue discount and accrued but unpaid interest into shares of the Company’s common stock at a fixed conversion price of $52.50 per share. The conversion option was available to the lender at the earlier of (i) maturity, or (ii) payback of all the principal. The embedded conversion option was not accounted for separately, in accordance with the guidance outlined in ASC 815-40, as it was considered indexed to the Company’s shares.   In connection with the New Note financing, the Company issued 26,000 common stock warrants with a five-year term at an exercise price of $52.50 per share, from which 13,000 common stock warrants were exercisable immediately and were exercisable in the event that the loan term is extended. At the time of issuance, the common stock warrants were valued at $252,940, which was recorded as an additional debt discount to the New Note. The issued common stock warrants were classified as equity as they were indexed to the Company’s shares in accordance with ASC 815-40.   During April 2023, the Company also modified the terms of the Prior Note and cancelled the original 12,000 common stock warrants issued with the Prior Note. The Company recognized the modification in accordance with ASC 815-40-35, which resulted in the recognition of debt discount in the amount of $35,981. In lieu of the cancelled common stock warrants, the Company issued 24,000 new common stock warrants with a five-year term at an exercise price of $52.50 per share. From the newly issued 24,000 new common stock warrants, 12,000 common stock warrants were fully vested and immediately exercisable, while the remaining 12,000 common stock warrants remained unvested. The issued common stock warrants were classified as equity as they were indexed to the Company’s shares in accordance with ASC 815-40.   In May of 2023, the Company renegotiated with the lender an extension of the maturity date of the Prior Note for six months to November 2023 with an increased annual interest rate of 20% and issued an additional 12,000 common stock warrants to the lender. The additional common stock warrants were valued at $94,083 and recorded as an additional debt discount. The issued common stock warrants were classified in equity as they were considered indexed to the Company’s shares in accordance with ASC 815-40. In connection with this extension, the 12,000 outstanding unvested warrants became vested and exercisable.   On July 31, 2023, the Company extended the maturity date of the New Note to November 30, 2023. In connection with such extension, 13,000 outstanding unvested common stock warrants became vested and exercisable. There was no change in the application of the accounting under ASC 815-40.   As of September 30, 2024 and December 31, 2023, the balance of the Prior Note, net of debt issuance costs, was $0 and $2,200,000, respectively. Interest expense related to the Prior Note, including interest incurred, amortization of the debt discount, and the warrant amortization for the three months ended September 30, 2024 and 2023 was $0 and $157,298, respectively. Interest expense related to the Prior Note, including interest incurred, amortization of the debt discount, and the warrant amortization for the nine months ended September 30, 2024 and 2023 was $121,000 and $762,112, respectively. As of September 30, 2024 and December 31, 2023, the balance of the New Note issued in April 2023, net of debt issuance costs, was $0 and $825,000 respectively. Interest expense related to the New Note, including interest incurred, amortization of the debt discount, and the warrant amortization for the three months ended September 30, 2024 and 2023 was $0 and $401,441. Interest expense related to the New Note, including interest incurred, amortization of the debt discount, and the warrant amortization for the nine months ended September 30, 2024 and 2023 was $45,205 and 401,441.   On April 9, 2024, the Company and the investor entered into an Amendment and Waiver Agreement relating to the Bridge Notes.    The Company agreed to pay $2.75 million in cash to the Investor in repayment of the principal of the Bridge Notes (exclusive of the $275,000 of original issue discount on the Bridge Notes) shortly after the closing by the Company of one or more equity financings with total gross proceeds to the Company of not less than $6,000,000.   On April 26, 2024, the Company repaid $2.75 million of principal on its Secured Bridge Notes.   Effective April 9, 2024, the Investor converted $911,384 (the “Rollover Amount”) which is equal to the (i) unpaid accrued interest on the Bridge Notes plus (ii) the original issue discount (“OID”) on the Bridge Notes, into equity securities of the Company (the “Rollover Securities”).   The Rollover Securities consist of (i) 463,337 prefunded common stock warrants with a per share exercise price of $0.001 per share (the “Prefunded Warrants”) and (ii) 463,337 non-prefunded warrants (the “Non-Prefunded Warrants”) with a per share exercise price equal to $1.967. As of the date and time of the Amendment and Waiver Agreement, the Nasdaq Minimum Price (as defined in the applicable Nasdaq listing rules) for the Company’s common stock was $1.966.   The number of Prefunded Warrants was determined by dividing the Rollover Amount by $1.967. The number of Non-Prefunded Warrants is equal to the number of Prefunded Warrants (i.e. 100% warrant coverage). The Non-Prefunded Warrants have a price adjustment provision which will adjust the exercise price downward in the event that the Company issues equity securities in the future at an effective per share price below the then current exercise price. In order to assure compliance with applicable Nasdaq rules, the Non-Prefunded Warrants shall not be exercisable for six months following the date of issue.   The Company issued to the Investor 50,000 new common stock warrants with a five-year term as a loan extension fee (“Fee Warrants”). The exercise price of these additional Fee Warrants is $1.967. The Fee Warrants have a price adjustment provision which will adjust the exercise price downward in the event that the Company issues equity securities in the future at an effective per share price below the then current exercise price. In order to assure compliance with applicable Nasdaq rules, the Fee Warrants shall not be exercisable for six months following the date of issue.   The Non-Prefunded Warrants and Fee Warrants had a total valuation of $811,402 and the Prefunded Warrants had a valuation of $732,370. As a result, the Company recorded $911,384 as a non-cash charge in connection with the issuance of warrants related to the Secured Bridge Notes and a change in the fair value of warrants of $632,388, which is included in other expense in the accompanying statements of operations. All Warrants were classified as equity as they were indexed to the Company’s shares in accordance with ASC 815-40.   The Company agreed to adjust the exercise price of the Investor’s Existing Warrants from $15.25 (after adjustment for the recent reverse stock) to $1.967 per share.   The Investor will not be able to receive shares upon exercise of any of the foregoing securities, unless prior stockholder approval is obtained, if (i) the number of shares to be issued would exceed 20% of the Company’s outstanding number of shares at a discount to the applicable Nasdaq Minimum Price or (ii) the number of shares to be issued would result in in a Change of Control within the meaning of Nasdaq Rule 5635(b).

v3.24.3

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5 – Commitments and Contingencies   Operating Lease   On March 25, 2024, the Company entered into a new 37-month operating lease commencing on April 1, 2024 with two separate two year renewal options. The monthly base rent for months two through 14 is $2,456, increasing to $3,070 for months 15 through 26, and ending at $3,684 for months 27 through 37. Rent expense, as part of general and administrative expenses in the condensed statement of operations, was $8,960 and $22,721 for the three and nine months ended September 30, 2024, respectively, which consisted of the new lease and a temporary month-to-month lease the Company entered into until a long-term space was identified. Rent expense was $12,053 and $49,491 for the three and nine months ended September 30, 2023, respectively, under the former lease that terminated in December 2023.   Litigation   In the normal course of business, the Company is party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company. There are no active litigations as of the date the financial statements were issued. However, a pre-IPO investor has contacted the Company claiming damages caused by alleged acts and omissions arising from a private financing by the Company. No complaint has been filed by the investor. The alleged damages asserted by the investor are less than approximately $300,000. The outcome of the complaint was neither probable or estimable as of the date the financial statements were issued, therefore, no accrual has been made.   NASDAQ Deficiencies   On November 21, 2023, the Company received a written notice from Nasdaq indicating that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Equity Requirement”). In the Company’s quarterly report on Form 10-Q for the period ended September 30, 2023, the Company reported stockholders’ equity of $2,415,012, and, as a result, did not satisfy Listing Rule 5550(b)(1). Nasdaq’s November written notice had no immediate impact on the listing of our common stock. The hearing with the Panel occurred on January 18, 2024, and addressed all outstanding listing compliance matters, including compliance with the Stockholders’ Equity Notice as well as compliance with the Bid Price Requirement.   On January 30, 2024, the Panel granted the Company’s request for an exception to Nasdaq’s listing rules until April 22, 2024, to demonstrate compliance with all applicable continued listing requirements for the Nasdaq Capital Market.   On April 16, 2024, the Company received a letter from Nasdaq granting an exception to the Exchange’s listing rules until May 20, 2024, to demonstrate compliance with Listing Rule 5550(b)(1) (the “Equity Rule”).   On May 24, 2024, the Company received a letter from Nasdaq indicating that the Company has regained compliance with the equity requirement in Listing rule 5550(b) (1) (the Equity Rule”.) The Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of the letter in accordance with application of Listing Rule 5815(d)(4)(B).   The Nasdaq listing rules require listed securities to maintain a minimum bid price of $1.00 per share. On October 16, 2024, the Company received a written notice from Nasdaq indicating that it was not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing. The Bid Price Notice does not result in the immediate delisting of the Company’s common stock from the Nasdaq Capital Market. The Bid Price Notice indicated that the Company has 180 calendar days (or until April 14, 2025) in which to regain compliance.   The Company’s receipt of these Nasdaq letters does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.

v3.24.3

Share-based Issuances	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Share-based Issuances	Note 6 – Share-based Issuances   Stock Options   The following table presents the activity for stock options outstanding:  Schedule of activity for stock options outstanding                 Options     Weighted Average Exercise Price   Outstanding - December 31, 2023     84,895     $ 47.79   Granted     –       –   Forfeited/canceled     (1,147 )     55.63   Exercised     –       –   Outstanding – September 30, 2024     83,748     $ 47.69                       Options     Weighted Average Exercise Price   Outstanding - December 31, 2022     66,527     $ 61.25   Granted     8,008       23.50   Forfeited/canceled     (8,258 )     37.75   Exercised     –       –   Outstanding – September 30, 2023     66,277     $ 59.50     The following table presents the composition of options outstanding and exercisable:  Schedule of options outstanding and exercisable                                   Options Outstanding**     Options Exercisable**   Exercise Prices   Number     Price     Life*     Number     Price*   $67.56     346     $ 67.56       0.04       346     $ 67.56   $72.39     2,131     $ 72.39       3.11       2,131     $ 72.39   $106.50     6,853     $ 106.50       4.73       6,853     $ 106.50   $69.75     30,891     $ 69.75       6.23       29,041     $ 69.75   $44.75     7,250     $ 44.75       6.93       4,175     $ 44.75   $30.25     15,577     $ 30.25       7.95       15,577     $ 30.25   $9.90     2,000     $ 9.90       8.69       500     $ 9.90   $6.25     18,700     $ 6.25       9.21       –     $ 6.25   Total – September 30, 2024     83,748                       58,623             * Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively. ** The Company’s options summarized above have been retroactively restated for the effect of the 25-for-1 reverse stock split.   Restricted Stock Units   The following table presents the activity for restricted stock units outstanding:  Schedule of activity for restricted stock units outstanding                 Restricted Stock Units     Weighted Average Grant Date Fair Value   Outstanding - December 31, 2023     11,490     $ 59.36   Granted     –       –   Forfeited/canceled     –       –   Vested/issued     (6,245 )     61.74   Outstanding – September 30, 2024     5,245     $ 56.52         Restricted Stock Units     Weighted Average Grant Date Fair Value   Outstanding - December 31, 2022     22,554     $ 53.50   Granted     1,500       31.00   Forfeited/canceled     (4,734 )     45.75   Vested/issued     (7,830 )     45.75   Outstanding – September 30, 2023     11,490     $ 59.25     The Company recognized share-based compensation expense related to stock options and restricted stock units of $119,416 and $217,141 for the three months ended September 30, 2024 and 2023, respectively, and $425,193 and $799,677 for the nine months ended September 30, 2024 and 2023, respectively. The remaining unvested share-based compensation expense of $295,304 is expected to be recognized over the next 39 months.

v3.24.3

Equity Financings	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Equity Financings	Note 7 – Equity Financings   Equity Line Sales of Common Stock   On November 14, 2022, the Company entered into a Common Stock Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC, a Nevada limited liability company (“White Lion”) for an equity line facility.   In April and June 2023, the Company closed on three sales of Common Stock under the White Lion Purchase Agreement. As a result, the Company issued an aggregate of 2,361,514 common shares and received aggregate proceeds of approximately $1.3 million.   Any proceeds that the Company receives under the White Lion Purchase Agreement are expected to be used for working capital and general corporate purposes.   The White Lion Purchase Agreement prohibits the Company from issuing and selling any shares of common stock to White Lion to the extent such shares, when aggregated with all other shares of our common stock then beneficially owned by White Lion, would cause White Lion’s beneficial ownership of common stock to exceed 9.99% (the “Beneficial Ownership Cap”).   The Company recognized all offering costs related to the equity line of credit as deferred offering costs in accordance with the guidance in ASC 835-30-S45.   Replacement Equity Line with White Lion   On November 6, 2023, the Company entered into a new Common Stock Purchase Agreement and a related registration rights agreement with White Lion. Pursuant to the new Common Stock Purchase Agreement, the Company has the right, but not the obligation to require White Lion to purchase, from time to time until December 31, 2024, up to $10,000,000 in aggregate gross purchase price of newly issued shares of the Company’s common stock, subject to certain limitations and conditions set forth in the Common Stock Purchase Agreement. In connection with the new Common Stock Purchase Agreement, the parties agreed to terminate the previous Common Stock Purchase Agreement with White Lion.   During the nine months ended September 30, 2024, the Company closed on several sales of Common Stock under the White Lion Purchase Agreement. As a result, the Company issued an aggregate of 4,815,263 common shares and received aggregate proceeds of approximately $8.2 million.   $2.3 Million Convertible Preferred Stock and Warrants Financing   On April 23, 2024, the Company entered into a securities purchase agreement with accredited investors for a convertible preferred stock and warrants financing. The Company received $2,314,000 of gross proceeds in connection with the closing of this financing.   At the closing, the Company issued 2,314 shares of Series B convertible preferred stock (“Series B Preferred Stock”) at a purchase price of $1,000 per share of Series B Preferred Stock. The Series B Preferred Stock is convertible into Common Stock at an initial conversion price (“Conversion Price”) of $1.851 per share of Common Stock. The Company also issued warrants (“Warrants”) exercisable for 1,250,137 shares of Common Stock with a five-year term and an initial exercise price of $1.851 per share.   The proceeds of this financing, together with other available cash resources, were used to repay outstanding debt and for general corporate purposes.   Holders of the Series B Preferred Stock will be entitled to dividends in the amount of 10% per annum, payable quarterly. The Company has the option to pay dividends on the Series B Preferred Stock in additional shares of Common Stock. The Company also has the option to cumulate or “capitalize” the dividends, in which case the accrued dividend amount shall be added to the stated value of each share of Series B Preferred Stock. As of September 30, 2024, the Company has elected to capitalize all dividends declared.    Warrants   The following table presents the activity for warrants outstanding: Schedule of activity for warrants outstanding                 Warrants     Weighted Average Exercise Price   Outstanding - December 31, 2023     216,884     $ 96.00   Granted     2,226,811       1.85   Forfeited/cancelled/restored     (14,154 )     –   Exercised     –       –   Outstanding – September 30, 2024     2,429,541     $ 15.00

v3.24.3

Leases under ASC 842	9 Months Ended
	Sep. 30, 2024
Leases Under Asc 842
Leases under ASC 842	Note 8 – Leases under ASC 842   The Company leases certain office space under operating leases for use in operations. The Company recognizes operating lease expense on a straight-line basis over the lease term. Management determines if an arrangement is a lease at contract inception. Lease and non-lease components are accounted for as a single component for all leases. Operating lease right to use (“ROU”) assets and liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the expected lease term, which includes optional renewal periods if the Company determines it is reasonably certain that the option will be exercised. As the operating lease does not provide an implicit rate, the discount rate used in the present value calculation represents the incremental borrowing rate determined using information available at the commencement date. For the three and nine months ended September 30, 2024, the Company recorded operating lease expense of $8,960 and $17,921, respectively, which is included in general and administrative expenses in the Company’s accompanying condensed statements of operations. As of September 30, 2024, weighted-average remaining lease term and discount rate were as follows: Schedule of weighted-average remaining lease term and discount rate           September 30, 2024   Weighted-average remaining lease term     4.8 years   Weighted-average discount rate     8.6%     The following is a maturity analysis of the annual undiscounted cash flows reconciled to the carrying value of the operating lease liabilities as of September 30, 2024: Schedule of annual undiscounted cash flows of leases       Years Ended December 31,       2024   $ 7,367   2025     34,382   2026     41,749   2027     14,735   Less imputed interest     (11,205 ) Total   $ 87,028

v3.24.3

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 9 – Subsequent Events   Management evaluated subsequent events and transactions that occurred after the balance sheet date, up to the date that the financial statements were issued. Based upon this review, other than as set forth below, management did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.   The Nasdaq listing rules require listed securities to maintain a minimum bid price of $1.00 per share. On October 16, 2024, the Company received a written notice from Nasdaq indicating that it was not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing. The Bid Price Notice does not result in the immediate delisting of the Company’s common stock from the Nasdaq Capital Market. The Bid Price Notice indicated that the Company has 180 calendar days (or until April 14, 2025) in which to regain compliance.

v3.24.3

Description of Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Description of Business	Description of Business   Auddia Inc., (the “Company”, “Auddia”, “we”, “our”) is a technology company that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company is incorporated in Delaware and headquartered in Colorado.
Basis of Presentation	Basis of Presentation   The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”).
Interim Financial Information	Interim Financial Information   The condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. The condensed balance sheet as of December 31, 2023 has been derived from the financial statements included in the Company’s annual report on Form 10-K. Accordingly, these condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K. The results for any interim period are not necessarily indicative of results for any future period. The Company recorded all adjustments necessary for a fair statement of the results for the interim period and all such adjustments are of a normal recurring nature.
Reverse Stock Split	Reverse Stock Split   The Company filed an amendment to its Certificate of Incorporation with the Secretary of State in Delaware which became effective as of 5:00 P.M. Eastern Time on February 26, 2024. As a result, every twenty-five (25) issued shares of common stock were automatically combined into one share of common stock.   Shares of the Company’s common stock were assigned a new CUSIP number (05072K 206) and began trading on a split-adjusted basis on February 27, 2024.   The reverse stock split did not change the authorized number of shares of the Company’s common stock. No fractional shares were issued and any fractional shares resulting from the reverse stock split were rounded up to the nearest whole share. Therefore, stockholders with less than 25 shares received one share of stock.   All stock amounts have been retrospectively adjusted to account for the reverse stock split. The reverse stock split applies to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable were adjusted proportionately as a result of the reverse stock split. The exercise prices of any outstanding warrants or stock options were also proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans.
Use of Estimates	Use of Estimates   The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.   The condensed financial statements include some amounts that are based on management’s best estimates and judgments. The most significant estimates relate to valuation of capital stock, warrants and options to purchase shares of the Company’s common stock, and the estimated recoverability and amortization period for capitalized software development costs. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Risks and Uncertainties	Risks and Uncertainties   The Company is subject to various risks and uncertainties frequently encountered by companies in the early stages of development. Such risks and uncertainties include, but are not limited to, its limited operating history, competition from other companies, limited access to additional funds, dependence on key personnel, and management of potential rapid growth. To address these risks, the Company must, among other things, develop its customer base; implement and successfully execute its business and marketing strategy; develop follow-on products; provide superior customer service; and attract, retain, and motivate qualified personnel. There can be no guarantee that the Company will be successful in addressing these or other such risks.
Emerging Growth Company Status	Emerging Growth Company Status   The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period to comply with certain new or revised accounting standards that have different effective dates for public and private companies.
Going Concern	Going Concern   The Company had cash and cash equivalents of $3,773,827 as of September 30, 2024. The Company will need additional funding to complete the development of the full product line and scale products with a demonstrated market fit. The Company raised an additional $10.4 million during 2024 and paid down $2.75 million in Secured Bridge Notes and will only be sufficient to fund our current operating plans into the first quarter of 2025. Management has plans to secure such additional funding. If the Company is unable to raise capital when needed or on acceptable terms, the Company will be forced to delay, reduce, or eliminate technology development and commercialization efforts.   As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. Management has plans to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern, such as the White Lion equity line of credit (refer to Note 7) and additional future financing agreements. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s current level of cash is not sufficient to execute the business plan. For the foreseeable future, the Company will incur significant operating expenses, capital expenditures and working capital funding that will deplete cash on hand during the first quarter of 2025.
Cash and Cash Equivalents	Cash and Cash Equivalents   The Company had cash on hand of $3,770,855 and $801,448 as of September 30, 2024 and December 31, 2023, respectively.   The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company had cash equivalents of $2,972 and $3,108 as of September 30, 2024 and December 31, 2023, respectively.   The Company maintains cash deposits at several financial institutions, which are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. As of September 30, 2024, the Company had approximately $3.5 million in excess of federally insured limits. As of December 31, 2023, the Company had approximately $0.6 million in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests.
Software Development Costs	Software Development Costs   The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable.   The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies.   Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are considered impaired and expensed during the period of such determination. The Company determined that no such impairments were required during the three and nine months ended September 30, 2024 and 2023. Software development costs of $258,734 and $213,705 were capitalized for the three months ended September 30, 2024 and 2023, respectively. Software development costs of $787,336 and $743,208 were capitalized for the nine months ended September 30, 2024 and 2023, respectively. Amortization of capitalized software development costs was $492,872 and $458,973 for the three months ended September 30, 2024, and 2023, respectively and $1,456,554 and $1,331,823 for the nine months ended September 30, 2024 and 2023, respectively, and is included in depreciation and amortization expense in the Company’s condensed statement of operations.
Revenue Recognition	Revenue Recognition   Revenue will be measured according to Accounting Standards Codification (“ASC”) 606, Revenue – Revenue from Contracts with Customers, and will be recognized based on consideration specified in a contract with a customer, and excludes any sales incentives and amounts collected on behalf of third parties. The Company will recognize revenue when a performance obligation is satisfied by transferring control over a service or product to a customer. The Company will report revenues net of any tax assessed by a governmental authority that is both imposed on, and concurrent with, a specific revenue-producing transaction between a seller and a customer in the condensed statements of operations. Collected taxes will be recorded within Other current liabilities until remitted to the relevant taxing authority.   Subscriber revenue will consist primarily of subscription fees and other ancillary subscription-based revenues. Revenue will be recognized on a straight-line basis when the performance obligations to provide each service for the period are satisfied, which is over time as our subscription services are continuously available and can be consumed by customers at any time. There is no revenue recognized for unpaid trial subscriptions.   Customers may pay for the services in advance of the performance obligation and therefore these prepayments would be recorded as deferred revenue. The deferred revenue will be recognized as revenue in the statement of operations as the services are provided.
Share-Based Compensation	Share-Based Compensation   The Company accounts for share-based compensation arrangements with employees, directors, and consultants and recognizes the compensation expense for share-based awards based on the estimated fair value of the awards on the date of grant in accordance with ASC 718.   Compensation expense for all share-based awards is based on the estimated grant-date fair value and recognized in earnings over the requisite service period (generally the vesting period). The Company records share-based compensation expense related to non-employees over the related service periods.   Certain share-based compensation awards include a net-share settlement feature that provides the grantee an option to withhold shares to satisfy tax withholding requirements and are classified as a share-based compensation liability. Cash paid to satisfy tax withholdings is classified as financing activities in the condensed statements of cash flows.
Warrants	Warrants   The Company account for warrants as equity-classified instruments, based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.   In connection with the amendment to the Secured Bridge Notes (see Note 4), the Company converted $911,384, consisting of accrued interest and the original issue discount on the Bridge Notes, into equity securities. As a result of the conversion, the Company recognized a change in the fair value of warrants in the amount of $0 and $632,388 during the three and nine months ended September 30, 2024.
Reclassifications	Reclassifications   Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not have an impact on net loss as previously reported.

v3.24.3

Property & Equipment, Intangible Assets, and Software Development Costs (Tables)	9 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Schedule of property and equipment and software development costs	Schedule of property and equipment and software development costs                 September 30, 2024     December 31, 2023                 Computers and equipment   $ 110,551     $ 102,348   Furniture     11,258       7,263   Accumulated depreciation     (107,581 )     (91,512 ) Total property and equipment, net   $ 14,228     $ 18,099                     Domain name   $ 3,947     $ 3,947   Accumulated amortization     (465 )     –   Total intangible assets, net   $ 3,482     $ 3,947                     Software development costs   $ 8,442,542     $ 7,655,206   Accumulated amortization     (5,763,826 )     (4,307,271 ) Total software development costs, net   $ 2,678,716     $ 3,347,935

v3.24.3

Accounts Payable and Accrued Liabilities (Tables)	9 Months Ended
	Sep. 30, 2024
Payables and Accruals [Abstract]
Schedule of accounts payable and accrued liabilities	Schedule of accounts payable and accrued liabilities                 September 30, 2024     December 31, 2023                 Accounts payable and accrued liabilities   $ 434,986     $ 424,510   Credit cards payable     6,740       16,975   Accrued interest     –       470,179   Total accounts payable and accrued liabilities   $ 441,726     $ 911,664

v3.24.3

Share-based Issuances (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of activity for stock options outstanding	Schedule of activity for stock options outstanding                 Options     Weighted Average Exercise Price   Outstanding - December 31, 2023     84,895     $ 47.79   Granted     –       –   Forfeited/canceled     (1,147 )     55.63   Exercised     –       –   Outstanding – September 30, 2024     83,748     $ 47.69                       Options     Weighted Average Exercise Price   Outstanding - December 31, 2022     66,527     $ 61.25   Granted     8,008       23.50   Forfeited/canceled     (8,258 )     37.75   Exercised     –       –   Outstanding – September 30, 2023     66,277     $ 59.50
Schedule of options outstanding and exercisable	Schedule of options outstanding and exercisable                                   Options Outstanding**     Options Exercisable**   Exercise Prices   Number     Price     Life*     Number     Price*   $67.56     346     $ 67.56       0.04       346     $ 67.56   $72.39     2,131     $ 72.39       3.11       2,131     $ 72.39   $106.50     6,853     $ 106.50       4.73       6,853     $ 106.50   $69.75     30,891     $ 69.75       6.23       29,041     $ 69.75   $44.75     7,250     $ 44.75       6.93       4,175     $ 44.75   $30.25     15,577     $ 30.25       7.95       15,577     $ 30.25   $9.90     2,000     $ 9.90       8.69       500     $ 9.90   $6.25     18,700     $ 6.25       9.21       –     $ 6.25   Total – September 30, 2024     83,748                       58,623             * Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively. ** The Company’s options summarized above have been retroactively restated for the effect of the 25-for-1 reverse stock split.
Schedule of activity for restricted stock units outstanding	Schedule of activity for restricted stock units outstanding                 Restricted Stock Units     Weighted Average Grant Date Fair Value   Outstanding - December 31, 2023     11,490     $ 59.36   Granted     –       –   Forfeited/canceled     –       –   Vested/issued     (6,245 )     61.74   Outstanding – September 30, 2024     5,245     $ 56.52         Restricted Stock Units     Weighted Average Grant Date Fair Value   Outstanding - December 31, 2022     22,554     $ 53.50   Granted     1,500       31.00   Forfeited/canceled     (4,734 )     45.75   Vested/issued     (7,830 )     45.75   Outstanding – September 30, 2023     11,490     $ 59.25

v3.24.3

Equity Financings (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of activity for warrants outstanding	Schedule of activity for warrants outstanding                 Warrants     Weighted Average Exercise Price   Outstanding - December 31, 2023     216,884     $ 96.00   Granted     2,226,811       1.85   Forfeited/cancelled/restored     (14,154 )     –   Exercised     –       –   Outstanding – September 30, 2024     2,429,541     $ 15.00

v3.24.3

Leases under ASC 842 (Tables)	9 Months Ended
	Sep. 30, 2024
Leases Under Asc 842
Schedule of weighted-average remaining lease term and discount rate	Schedule of weighted-average remaining lease term and discount rate           September 30, 2024   Weighted-average remaining lease term     4.8 years   Weighted-average discount rate     8.6%
Schedule of annual undiscounted cash flows of leases	Schedule of annual undiscounted cash flows of leases       Years Ended December 31,       2024   $ 7,367   2025     34,382   2026     41,749   2027     14,735   Less imputed interest     (11,205 ) Total   $ 87,028

v3.24.3

Description of Business, Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)			3 Months Ended		9 Months Ended
	Apr. 26, 2024	Apr. 09, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Debt Instrument [Line Items]
Cash and cash equivalents			$ 3,773,827		$ 3,773,827		$ 804,556
Capital raised					10,400,000
Repayments of debt					2,750,000
Cash on hand			3,770,855		3,770,855		801,448
Cash equivalents			2,972		2,972		3,108
Cash in excess of federally insured limits			3,500,000		3,500,000		$ 600,000
Impairment of software development costs			0	$ 0	0	$ 0
Software development costs			258,734	213,705	787,336	743,208
Amortization of software development costs			492,872	458,973	1,456,554	1,331,823
Change in fair value of warrants			(0)	$ (0)	632,388	$ (0)
Secured Bridge Notes [Member]
Debt Instrument [Line Items]
Change in fair value of warrants			$ 0		$ 632,388
Bridge Note [Member]
Debt Instrument [Line Items]
Repayments of debt	$ 2,750,000
Conversion of stock, amount converted		$ 911,384

v3.24.3

Property & Equipment, Intangible Assets, and Software Development Costs (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Computers and equipment	$ 110,551	$ 102,348
Furniture	11,258	7,263
Accumulated depreciation	(107,581)	(91,512)
Total property and equipment, net	14,228	18,099
Domain name	3,947	3,947
Accumulated amortization	(465)	0
Total intangible assets, net	3,482	3,947
Software development costs	8,442,542	7,655,206
Accumulated amortization	(5,763,826)	(4,307,271)
Total software development costs, net	$ 2,678,716	$ 3,347,935

v3.24.3

Property & Equipment, Intangible Assets, and Software Development Costs (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 3,291	$ 6,193	$ 16,069	$ 18,997
Amortization of intangible assets	202	0	465	0
Amortization of software development costs	$ 492,872	$ 458,973	$ 1,456,554	$ 1,331,823

v3.24.3

Accounts Payable and Accrued Liabilities (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accounts payable and accrued liabilities	$ 434,986	$ 424,510
Credit cards payable	6,740	16,975
Accrued interest	0	470,179
Total accounts payable and accrued liabilities	$ 441,726	$ 911,664

v3.24.3

Notes Payable to Related Party, net of debt issuance costs (Details Narrative) - USD ($)			1 Months Ended			3 Months Ended		9 Months Ended
	Apr. 26, 2024	Apr. 09, 2024	May 31, 2023	Apr. 30, 2023	Nov. 30, 2022	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Jul. 31, 2023
Debt Instrument [Line Items]
Debt instrument, principal amount								$ 2,750,000
Common stock per share value		$ 1.966
Fair value of warrants						$ (0)	$ (0)	632,388	$ (0)
Non Prefunded Warrants And Fee Warrants [Member]
Debt Instrument [Line Items]
Warrants outstanding, value								811,402
Secured Bridge Note Warrants [Member]
Debt Instrument [Line Items]
Non-cash charge for warrants		$ 911,384
Fair value of warrants		$ 632,388
Prefunded Warrants [Member]
Debt Instrument [Line Items]
Warrants exercise price		$ 0.001
Warrants outstanding, value								$ 732,370
Number of warrants		463,337
Non Prefunded Warrants [Member]
Debt Instrument [Line Items]
Warrants exercise price		$ 1.967
Investors Existing Warrants [Member] | Maximum [Member]
Debt Instrument [Line Items]
Warrants exercise price		15.25
Investors Existing Warrants [Member] | Minimum [Member]
Debt Instrument [Line Items]
Warrants exercise price		1.967
Fee Warrants [Member]
Debt Instrument [Line Items]
Warrants outstanding								50,000
Warrants exercise price		$ 1.967
Prior Note [Member]
Debt Instrument [Line Items]
Debt instrument, principal amount					$ 2,200,000
Debt instrument, unamortized discount					$ 200,000
Conversion price					$ 30.75
Warrants outstanding					12,000
Warrants exercise price					$ 52.50
Warrants outstanding, value					$ 361,878
Debt issuance costs						0		$ 0		$ 2,200,000
Interest expense						0	157,298	121,000	762,112
Prior Note [Member] | Additional Common Stock Warrants [Member]
Debt Instrument [Line Items]
Warrants outstanding			12,000
Warrants outstanding, value			$ 94,083
Number of warrants vested and exercisable			12,000
Prior Note [Member] | New Common Stock Warrants [Member]
Debt Instrument [Line Items]
Warrants exercise price				$ 52.50
Warrants cancelled shares				12,000
Debt discount				$ 35,981
Warrants issued, shares				24,000
Prior Note [Member] | New Common Stock Warrants [Member] | Fully Vested [Member]
Debt Instrument [Line Items]
Warrants issued, shares				12,000
New Note [Member]
Debt Instrument [Line Items]
Debt instrument, principal amount				$ 825,000
Debt instrument, unamortized discount				$ 75,000
Conversion price				$ 52.50
Debt issuance costs						0		0		$ 825,000
Interest expense						$ 0	$ 401,441	$ 45,205	$ 401,441
New Note [Member] | Additional Common Stock Warrants [Member]
Debt Instrument [Line Items]
Warrants outstanding				26,000
Warrants exercise price				$ 52.50
Warrants exercisable				13,000
Warrants issued, value				$ 252,940
Number of warrants vested and exercisable											13,000
Bridge Note [Member]
Debt Instrument [Line Items]
Debt instrument, principal amount		$ 2,750,000
Debt instrument, unamortized discount		275,000
Gross proceeds from financing		6,000,000
Debt instrument, principal amount	$ 2,750,000
Rollover amount		$ 911,384

v3.24.3

Commitments and Contingencies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 8,960	$ 12,053	$ 22,721	$ 49,491
Stockholders' equity minimum balance		$ 2,415,012

v3.24.3

Share-based Issuances (Details - Option activity) - Equity Option [Member] - $ / shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding, beginning	84,895	66,527
Weighted average exercise price outstanding, beginning	$ 47.79	$ 61.25
Options granted	0	8,008
Weighted average exercise price, granted	$ 0	$ 23.50
Options forfeited/canceled	(1,147)	(8,258)
Weighted average exercise price, forfeited/canceled	$ 55.63	$ 37.75
Options exercised	0	0
Weighted average exercise price, exercised	$ 0	$ 0
Options outstanding, ending	83,748	66,277
Weighted average exercise price outstanding, ending	$ 47.69	$ 59.50

v3.24.3

Share-based Issuances (Details - Options by exercise price) - Equity Option [Member] - $ / shares		9 Months Ended
		Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding		83,748	84,895	66,277	66,527
Weighted average exercise price - options outstanding		$ 47.69	$ 47.79	$ 59.50	$ 61.25
Options exercisable		58,623
$67.56 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding		346
Weighted average exercise price - options outstanding		$ 67.56
Weighted average contractual term	[1]	14 days
Options exercisable		346
Weighted average exercise price - options exercisable	[1]	$ 67.56
$72.39 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding		2,131
Weighted average exercise price - options outstanding		$ 72.39
Weighted average contractual term	[1]	3 years 1 month 9 days
Options exercisable		2,131
Weighted average exercise price - options exercisable	[1]	$ 72.39
$106.50 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding		6,853
Weighted average exercise price - options outstanding		$ 106.50
Weighted average contractual term	[1]	4 years 8 months 23 days
Options exercisable		6,853
Weighted average exercise price - options exercisable	[1]	$ 106.50
$69.75 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding		30,891
Weighted average exercise price - options outstanding		$ 69.75
Weighted average contractual term	[1]	6 years 2 months 23 days
Options exercisable		29,041
Weighted average exercise price - options exercisable	[1]	$ 69.75
$44.75 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding		7,250
Weighted average exercise price - options outstanding		$ 44.75
Weighted average contractual term	[1]	6 years 11 months 4 days
Options exercisable		4,175
Weighted average exercise price - options exercisable	[1]	$ 44.75
$30.25 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding		15,577
Weighted average exercise price - options outstanding		$ 30.25
Weighted average contractual term	[1]	7 years 11 months 12 days
Options exercisable		15,577
Weighted average exercise price - options exercisable	[1]	$ 30.25
$9.90 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding		2,000
Weighted average exercise price - options outstanding		$ 9.90
Weighted average contractual term	[1]	8 years 8 months 8 days
Options exercisable		500
Weighted average exercise price - options exercisable	[1]	$ 9.90
$6.25 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding		18,700
Weighted average exercise price - options outstanding		$ 6.25
Weighted average contractual term	[1]	9 years 2 months 15 days
Options exercisable		0
Weighted average exercise price - options exercisable	[1]	$ 6.25
[1] Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.

v3.24.3

Share-based Issuances (Details - Restricted stock units activity) - Restricted Stock Units (RSUs) [Member] - $ / shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock units outstanding, beginning	11,490	22,554
Weighted average exercise price outstanding, beginning	$ 59.36	$ 53.50
Restricted stock units granted	0	1,500
Weighted average grant date fair value, granted	$ 0	$ 31.00
Restricted stock units forfeited/canceled	0	(4,734)
Weighted average grant date fair value, forfeited/canceled	$ 0	$ 45.75
Restricted stock units vested/issued	(6,245)	(7,830)
Weighted average grant date fair value, vested/issued	$ 61.74	$ 45.75
Restricted stock units outstanding, ending	5,245	11,490
Weighted average exercise price outstanding, ending	$ 56.52	$ 59.25

v3.24.3

Share-based Issuances (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Equity [Abstract]
Share-based compensation	$ 119,416	$ 217,141	$ 425,193	$ 799,677
Unvested share-based compensation expense to be recognized			$ 295,304

v3.24.3

Equity Financings (Details - Warrant activity) - Warrant [Member]	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding, beginning | shares	216,884
Weighted average exercise price outstanding, beginning | $ / shares	$ 96.00
Warrants granted | shares	2,226,811
Weighted average exercise price, granted | $ / shares	$ 1.85
Warrants forfeited/cancelled/restored | shares	(14,154)
Weighted average exercise price, forfeited/cancelled/restored | $ / shares	$ 0
Warrants exercised | shares	0
Weighted average exercise price, exercised | $ / shares	$ 0
Warrants outstanding, ending | shares	2,429,541
Weighted average exercise price outstanding, ending | $ / shares	$ 15.00

v3.24.3

Equity Financings (Details Narrative) - USD ($)		1 Months Ended		9 Months Ended
	Apr. 23, 2024	Jun. 30, 2023	Apr. 30, 2023	Sep. 30, 2024	Dec. 31, 2023
Class of Stock [Line Items]
Aggregate proceeds				$ 10,400,000
Warrant [Member]
Class of Stock [Line Items]
Warrants exercisable	1,250,137
Warrants exercise price	$ 1.851			$ 15.00	$ 96.00
Common Stock [Member] | White Lion Purchase Agreement [Member]
Class of Stock [Line Items]
Number of shares issued, shares				4,815,263
Aggregate proceeds				$ 8,200,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Conversion of shares, shares	2,314
Purchase price	$ 1,000
Conversion price	$ 1.851
White Lion Purchase Agreement [Member] | Common Stock [Member]
Class of Stock [Line Items]
Number of shares issued, shares		2,361,514	2,361,514
Aggregate proceeds		$ 1,300,000	$ 1,300,000
Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Gross proceeds	$ 2,314,000

v3.24.3

Leases under ASC 842 (Details - Lease cost)	Sep. 30, 2024
Leases Under Asc 842
Weighted-average remaining lease term	4 years 9 months 18 days
Weighted-average discount rate	8.60%

v3.24.3

Leases under ASC 842 (Details - Lease maturity)	Sep. 30, 2024 USD ($)
Leases Under Asc 842
2024	$ 7,367
2025	34,382
2026	41,749
2027	14,735
Less imputed interest	(11,205)
Total	$ 87,028

v3.24.3

Leases under ASC 842 (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating lease expense	$ 8,960	$ 12,053	$ 22,721	$ 49,491
Office Space [Member]
Operating lease expense	$ 8,960		$ 17,921

---